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The Forensic Chemistry Laboratory, Cape Town, analyses samples submitted by forensic 
pathologists in order to assist with determining the cause of death in cases of unnatural 
death. Many of these samples test positive for the presence of drugs and other toxic 
substances. Because of resource constraints, pathologists submit samples at their 
discretion and not on a routine basis. In this study, forensic and chemical aspects were 
combined and used as the motivation for the development of an improved extraction 
procedure for systematic toxicological analysis. 
The scope of the study was therefore twofold. Firstly, a study was undertaken of 
unnatural deaths in the greater Cape Town area for which samples would not normally 
have been submitted. The results of this study indicated that cases of unnatural death 
should be submitted on a more routine basis, as 30 % of the samples tested positive for 
the presence of drugs. Secondly, solid-phase extraction, using spiked urine samples, 
was investigated as an alternative extraction procedure after the results indicated a need 
for a drug extraction procedure that would be able to isolate various classes of drugs 
during a single procedure with only one extraction cartridge. 
Solid-phase extraction was compared with methods currently being used at the Forensic 
Chemistry Laboratory, Cape Town. The research focused on drugs that had previously 
been detected and included various classes of drugs with different properties. The 
selection comprised cocaine, imipramine, lorazepam, methamphetamine, oxazepam, 
phenobarbital and secobarbital, with prazepam being used as an internal standard. 
Clean Screen® DAU and Xtrackr® columns from United Chemical Technologies were 
investigated for their extraction efficiency, and the use of dimethyl formam ide as a 
"keeper" solvent, which is a solvent that prevents the evaporation of volatile components, 
was also studied. It was found that solid-phase extraction had a higher extraction 
efficiency than the current methods employed and that the Xtrackr® cartridge used 
together with dimethyl formamide gave the highest recovery for the drugs that were 
spiked in urine. This column was also successfully used for the extraction of drugs from 
post-mortem blood, stomach contents and cerebrospinal fluid. The solid-phase 
extraction method was successfully validated for the extraction of drugs from urine, using 
an Xtrackr® column, and a gas chromatograph with nitrogen-phosphorus detection was 
used for the determination of selectivity, accuracy, intra-assay precision, intermediate 











Some of the results of the study to determine the extent of drug and ethanol use, which 
are given in Chapter 3, have been published previously: 
The International Association of Forensic Toxicologists (TIAFT) 43rd International 
Meeting, Seoul, Korea. 29 August - 2 September 2005. Poster presentation. The 
pattern of drug and alcohol use in victims of unnatural death in Cape Town, South Africa. 













1.1 FORENSIC SCIENCE 
Forensic science is the field in which scientific techniques are used to 
obtain evidence relevant to legal proceedings. In 1910 Edmond Locard 
formulated the "contact trace theory", which simply states that if two 
objects meet, evidence of that meeting can later be found and verified. 
This forms the foundation of forensic science [1]. 
Forensic science has come a long way since its early beginnings in the 
sixteenth century in Europe, when medical practitioners in army and 
university settings began to gather information on cause and manner of 
death. Writings on these topics began to appear in the late 1700s and 
included A Treatise on Forensic Medicine and Public Health, by the 
French physiCian FoderE~, and The Complete System of Police 
Medicine, by the German medical expert Johann Peter Franck [2]. 
One of the first uses of physical matching occurred in 1816 when a 
farm labourer was convicted of the homicide of a young maidservant. 
The police found an impression of a corduroy cloth with a sewn patch 
in the damp earth on the scene. This evidence corresponded exactly 
to the breeches of a farm labourer who had been threshing wheat 
nearby [2]. 
The basis of the investigation of a crime is the assembling of a 
sequence of facts that will assist the judicial process to be carried to a 
satisfactory conclusion. This process requires the application of 
various sciences to answer questions relating to biological evidence 
(by means of the DNA analysis of physiological fluids, for example), 











and tyre tracks, controlled substances, ballistics, and other evidence 
such as exhibits found at the scene of the crime. Such evidence is 
ultimately delivered to a forensic science laboratory, where skilled 
personnel perform analyses using analytical instrumentation. 
1.2 FORENSIC TOXICOLOGY 
Toxicology is the scientific study of toxins or poisons. A poison can be 
defined as a chemical substance that may be harmful to living 
organisms. It was Paracelsus who observed that anything can be a 
poison if it exceeds the threshold limit of an organism's ability to deal 
with it [3]. 
Toxicity is a biological concept and is usually determined by some sort 
of bioassay. Chemical analysis, however, is required to detect the 
presence of a toxin, identify it and measure its concentration, which 
must then be related to its known toxicity. Forensic toxicology is 
essentially the analysis of samples to determine the presence and 
concentration of drugs, alcoh l and poisons in the body, followed by 
the interpretation of those results, which are typically used in a court of 
law. The use of forensic toxicology is crucial to the outcome of many 
legal cases, as it enables hard scientific evidence to be presented in 
court. 
The first person to suggest a chemical method for the detection of 
poisons, according to Thorvald Jurgen in The Century of the Detective, 
was Dr Hermann Boerhaave [4]. His method, which was relatively 
unsophisticated, consisted of placing substances suspected of 
containing poison on red-hot coals and then testing the subsequent 
odours. In the early stages of forensic toxicology, arsenic was the 
most common poison of choice. It was known as the "poison of 
poisons" or as "inheritance powder", since many relatives used it to kill 











Forensic toxicology became a scientific discipline in the nineteenth 
century. The first internationally acclaimed work on this subject was 
Traite des poisons, by Matieiv J B Orfila, which was published in 1813 
[3]. It was the first systematic approach to the study of the chemical 
and physiological nature of poisons, and won its author the title of 
"Father of Toxicology" [3]. 
Another major step in the history of forensic toxicology was the 
development of methods for detecting the presence of plant alkaloids 
such as caffeine, quinine, morphine, strychnine, atropine and opium. 
Alkaloids leave no easily demonstrable traces in the human body and 
therefore require relatively complicated methods of extraction before an 
analysis can be performed. These poisons affect the central nervous 
system. Even Orfila had no success and he thought that the isolation 
of alkaloids from human tissues might be altogether impossible [3]. 
Orfila's student, Jean Servois Stas, had a different idea. In a homicide 
trial in 1850, a male victim showed clear chemical burns in his mouth, 
tongue and throat. Stas searched for three months for the agent and 
eventually managed to isolate nicotine from the body tissues. Using 
ether as a solvent, which he then evaporated to isolate the drug, he 
found the potent drug [5]. Several years later the extraction method 
was modified by F J Otto and became known as the Stas-Otto method 
[4]. 
Societies of forensics and toxicology such as the American Academy of 
Forensic Sciences (AAFS), The International Association of Forensic 
Toxicologists (TIAFT) and the Society of Forensic Toxicologists (SOFT) 
have been established to promote the cause of forensic toxicology, 
advance education in the field, and ensure knowledgeable input into 
standards governing the profession. Since 1991 the profession has 
matured in many ways. In 1996 the American Board of Forensic 
Toxicology launched a Forensic Toxicology Accreditation program 











State passed legislation requiring the accreditation of all forensic 
laboratories in the public sector [6]. 
Compared with toxicologists in academic research or industry, forensic 
toxicologists face a task that is made more difficult by limited analytical 
material, severe time constraints, and generally limited resources at 
government laboratories. Forensic toxicology demands an overall 
analytical system designed to indicate or exclude the presence of any 
poison in each of the chemical groups shown in Figure 1.1. Most of the 
numerous screening procedures reported in the literature are too 
limited to permit a negative result to be reported with confidence. They 
are often oriented in classes or groups of drugs, despite the fact that 

















Figure 1.1 Chemical grouping of poisons [3] 
Apart from analytical problems, the legal aspect of the work demands 
scrupulous attention to detail. Failure to make full descriptive notes on 











performed, or neglecting to check reagent purity, can become evidence 
of careless work in the hands of an astute lawyer. The identification 
and quantification of the poison may be faultless and the conclusions 
correct, but, if the court's confidence in the forensic toxicologist as an 
unbiased scientific expert is destroyed, the case may be lost [3]. 
Guiding principles for forensic toxicology established by Orfila over 100 
years ago are summarized as follows [5]: 
• All chemists undertaking this work must have forensic 
experience. 
• The analyst must be given a complete case history containing all 
the information available. 
• All the evidential material, suitably sealed and labelled, must be 
submitted and examined. 
• All the known identification tests should be applied and 
adequate notes made at the time. 
• All the necessary test reagents should be pure, and blank tests 
should be performed to establish this fact. 
• All tests should be repeated and compared to control samples to 
which the suspected toxin has been added. 
Adherence to these principles makes forensic toxicology one of the 
slowest and most expensive forms of analysis; this must, however, be 
accepted to ensure justice for the victim and the accused [5]. 
1.3 BACKGROUND 
With the change of government in South Africa in 1994, social, political 
and economic transitions occurred that resulted in rapid urbanization 
and greater unemployment. Because of these transitions, increased 











South Africa's re-entry into the global market system created conditions 
that were conducive to the flow of illegal drugs into the country through 
drug syndicates. The country's ideal geographical position and solid 
infrastructure have made South Africa particularly vulnerable to drug 
trafficking [8, 9]. Research indicates that substance abuse has been a 
problem in Cape Town for many years, with alcohol being the most 
widely abused legal substance [9]. 
The influx of illegal drugs into the county led to a drop in prices [8, 9]. 
Drugs (such as cocaine) that were formerly affordable only by wealthy 
South Africans, suddenly became accessible even to the previously 
disadvantaged section of the population. Cocaine prices, for example, 
fell by 53 % between 1992 and 1998, and formerly "elite" drugs 
became more than a third cheaper compared to North America [9]. 
This price reduction was even more marked for drugs such as Mandrax 
(the active ingredient of which is methaqualone) and cannabis (a major 
component of which is Ll9-tetrahydrocannabinol (Ll9-THC» [3]. 
The influx of drugs into South Africa and more specifically the port city 
of Cape Town, has created a climate in which crime and violence can 
flourish. Drugs such as methaqualone are generally associated with 
crime, violence and gang-related activities. Although methaqualone 
can be used orally, this mode of use is rare in South Africa, with users 
preferring to smoke it in a mixture with cannabis and tobacco in a 
unique South African drug combination called the "white pipe" [10]. 
Worldwide, drug and alcohol abuse are generally associated with the 
incidence of violence and crime [11]. Risky behaviour as a result of 
drug and alcohol abuse often leads to death, which in such cases 
would be classified as unnatural death or death due to unnatural 
causes. This is also the trend in South Africa [11]. Data on drugs 
present in unnatural death cases are provided to the mortuaries by the 
Forensic Chemistry Laboratory, Cape Town (FCL CTN). In South 











screening, but, because of limited laboratory resources, mortuaries 
send cases for toxicological screening only at the discretion of the 
pathologist. This means that not all cases of unnatural death are 
toxicologically analysed for drugs and, as a result, the data reported by 
surveillance centres such as the Medical Research Council (MRC) are 
inaccurate. 
1.4 EXTENT OF DRUG AND ALCOHOL USE IN THE GREATER 
CAPE TOWN AREA 
Organizations such as the MRC, the South African Community 
Epidemiological Network on Drug Use (SACENDU) and the Human 
Sciences Research Council of South Africa (HSRC) have done 
extensive research into the alcohol and drug abuse problem in Africa 
and South Africa [10-14]. Charles Parry and associates carry out 
projects that monitor the trends of drug and alcohol use and the 
associated consequences on a six-monthly basis [10, 15]. Their 
"surveillance system" has done substantial work in highlighting the 
prevalence of drugs of abuse such as cannabis, methaqualone, 
cocaine and heroin, as well as alcohol, in South Africa. Their research 
has indicated that, since the inception of this program, all sentinel sites 
in South Africa except Cape Town have shown a drop in treatment 
demand [10]. The HSRC has confirmed these reports and has found 
that the Western Cape in particular exhibits a definite relationship 
between the level of drug and alcohol use, and crime [9, 13]. 
According to reports by the National Injury and Violence Surveillance 
Initiative, as well as numerous others [10-12], the risk of injury is 
increased by the intake of alcohol, both internationally and locally. 
Much less, however, is known about other drugs and their association 
with unnatural death, particularly in South Africa, where their availability 











1.5 FORENSIC PATHOLOGY LABORATORY PROCEDURES 
In terms of the Inquests Act (No 58 of 1959) and the Births and Deaths 
Registration Act (No 52 of 1992), all unnatural deaths and deaths due 
to undetermined causes must be subjected to medico-legal 
investigation. Victims are presented to the forensic pathology 
laboratories on a 24 hour basis. The purpose of the medico-legal 
autopsy is to determine the cause of death and make a medical 
determination of all the other factors that may be involved in the death. 
The autopsy provides the pathologist with an opportunity to examine 
the body both externally and internally to determine what wounds and 
injuries were sustained and to determine the cause of death. In some 
instances the cause of death cannot be determined, because of the 
condition of the body or the circumstances surrounding its discovery. 
In such a case, if the pathologist suspects that, deliberately or 
accidentally, poisoning, an overdose of medication, drugs of abuse, 
inhalation of volatile compounds, or alcohol might be involved, it is 
referred to a Forensic Chemistry Labor tory. Body fluids are sampled 
from the body and, if necessary, organs are removed. The samples 
are placed in toxicology and bl od alcohol kits and sealed with unique 
seal numbers to preserve the "chain of custody", a term that refers to 
the actions taken to maintain the integrity of samples. The samples are 
then transported to the Forensic Chemistry Laboratory, where they are 
received, registered and bar coded. 
1.6 CURRENT FORENSIC CHEMISTRY LABORATORY 
PROCEDURES 
The FCL CTN is one of three Laboratories within the Directorate 
Forensic Pathology Services in the Cluster Non-Communicable 
Diseases of the National Department of Health. At the FCLs, biological 
and foodstuffs samples are analysed in terms of the Inquests Act (No 
58 of 1959), the Road Traffic Act (No 93 of 1996), the Drugs and Drug 
Trafficking Act (No 140 of 1992), the Criminal Procedure Act (No 51 of 











1972). The FCL CTN delivers an analytical service to clients in the 
Western, Eastern and Northern Cape provinces. The FCLs in 
Johannesburg and Pretoria deliver a similar service to the other six 
provinces. The FCL CTN has three operational sections, which deal 
with the analysis of samples in the areas of toxicology, blood alcohol 
and food respectively. 
The toxicology section receives on average 2 000 cases per annum to 
determine the presence and quantity of toxic substances such as 
drugs, medicine, heavy metals, volatiles and pesticides. The samples 
are received in sealed containers at reception after which they are 
registered and bar coded on a Laboratory Information Management 
System (LlMS). Two toxicology kits are available for use by 
pathologists: one is used for body fluids and the other one for organs. 
Only body fluids are usually analysed unless a request is received from 
the pathologist for the analysis of organs. The analysis requested, 
together with other relevant information, is indicated on the toxicology 
request form accompanying the samples. The kits are stored in a cold 
room at 5 °C until analysis. The samples are extracted using liquid-
liquid extraction methods and the extracts are analysed on analytical 
instruments such as gas chromatographs (GC), GCs with mass 
selective detectors (GC-MS), high-performance liquid chromatographs 
(HPLC) and liquid chromatographs with mass-selective detectors (LC-
MS/MS). 
The blood alcohol section receives on average 13 000 ante-mortem 
(drunken driving) and 8000 post-mortem samples for alcohol analysis 
per annum. Samples for alleged drunken driving are analysed in terms 
of section 212 of the Criminal Procedure Act. While keeping the chain 
of custody, the samples are opened, diluted with an internal standard 
and analysed using two GCs with flame-ionization detectors (GC-FID) 
under different operating conditions. The sodium fluoride 











1.7 EXTRACTION METHODS 
The toxicology samples are extracted using liquid-liquid extraction 
(LLE) procedures. One of the methods consists of a two-step 
procedure in which ammonia is added to the biological fluid to ensure 
an alkaline medium, followed by extraction with butyl acetate. This 
method is referred to as the butyl acetate extraction method [16]. It 
enables reliable screening and quantification of basic drugs at 
therapeutic and toxic concentration levels in post-mortem biological 
fluids to be done. 
The cause of acidity and basicity was explained in 1884 by the 
Swedish chemist Svante Arrhenius, who said that acids are substances. 
that increase the concentration of hydrogen ions in aqueous solution, 
and bases are substances that increase the concentration of hydroxide 
ions in solution. More specific to molecules and ions, however, is the 
Bn2msted-Lowry concept (formulated by the Danish chemist Johannes 
Br0nsted and the British chemist Thomas Lowry in 1923), which says 
that the acid in a proton-transfer reaction is the species donating the 
proton, and the base is the species accepting the proton. 
Acid-base chemistry is a vital aspect of drug chemistry and analysis, 
and drugs can be classified as acidic, basic or neutral. The functional 
groups that define their classes are amine groups for bases, and 
typically phenolic and carboxyl groups for acids. A drug molecule can 
have more than one acid or base group, each one of which is called an 
ionizable centre. 
Amines are a major class of organic compounds and constitute most of 
the drug types encountered in forensic work. These are mainly basic 
drugs in that they act as proton acceptors in aqueous solutions. 
Amphetamine is a typical example of an amine-containing drug: when it 












amphetamine-NH2 + H20 ~ amphetamine-NH3 + + OH-
Blood and urine are also aqueous systems and follow similar 
considerations. In the literature, acidic and basic drugs are referred to 
as acids and bases, and this terminology will be used from here on [17-
29]. 
The FCL CTN uses an LLE method in which basic drugs are converted 
back to their neutral form by the addition of ammonia solution to the 
blood or urine sample. An organic solvent, butyl acetate, is then used 
to extract the non-ionized form of the drug. 
Given the widespread abuse of drugs in the greater Cape Town area 
and because of requests from pathologists based on drugs found at the 
death scene and observations during autopsies, this procedure has 
been used at the FCL CTN for all cases where drugs of abuse were 
suspected [16]. This extraction method, however, extracts mainly 
drugs that contain amine groups, that is, basic drugs. Common drugs 
of abuse such as lysergic acid diethylamide (LSD), and ibuprofen, are 
not extracted by this method and would therefore go undetected. This 
is also the case with morphine, an amphoteric drug whose charge 
depends on the pH of the matrix. As a result, it is not always detected 
using the butyl acetate extraction method and its percentage recovery 
is variable. 
The other extraction procedure used at the FCL CTN, called the Celite 
extraction method, is based on the principles described by Missen [30] 
and Wood [31]. Celite is a calcined diatomaceous earth. In this 
method, the biological fluid is mixed with internal standard, potassium 
iodide, borate buffer and Celite powder and packed into a column. The 











1.8 NEW METHODS 
Over the past decade solid-phase extraction (SPE) has emerged as a 
powerful tool for selective chemical extraction and purification [17, 18]. 
From trace level sample preparation to industrial-scale chemical 
extraction, it plays an increasingly prominent role in a broad range of 
applications: forensic, pharmaceutical, fine chemical, biomedical, food 
analysis, organic synthesis, environmental and many others. Bonded 
silica sorbents, which consist of silica gel particles that have been 
reacted with organosilane reagents, are widely used as solid stationary 
phases in SPE work. The silica gel particles comprise a core of silicon 
atoms joined with oxygen atoms by siloxane (silicon-oxygen-silicon) 
bonds. Organosilane reagents containing various types of functional . 
groups react with the silica gel substrate to form the bonded silica 
sorbent. The functional groups give the sorbent its analyte-retaining 
properties. These sorbents are rigid and do not shrink or expand in 
different solvents, unlike many polystyrene-based resins. This stability 
means that equilibrium is rapidly attained when solvent conditions are 
changed, enabling extraction procedures involving many solvents to be 
carried out in a short period of time [20-34]. 
Although in the past SPE was preferred for the selective extraction of 
specific drugs or drug groups, it has recently been proposed for 
screening purposes [17, 18]. Traditional LLE procedures are rapidly 
being replaced by SPE procedures, which use less solvent and are 
therefore safer and more cost-effective. The main reason is, however, 
that during the SPE process, the sample is selectively extracted, 
concentrated and purified on the extraction column. The analytes of 
interest in biological material are normally at very low concentrations 

















Figure 1.2 A typical SPE column 
(modified from [20]) 
SPE is a method used for rapid sample preparation in which a solid 
stationary phase is packed into a syringe barrel. as shoVllll in Figure 
1 2 
1.9 REVIEW OF EXTRACTION METHODS 
The extrflction of drugs from biological matrices during a routine 
toxicological analYSIs is necessary in order to determine the cause of 
death. The procedure should be capable of extracting a wide range of 
compounds and at the same time should be able to remove 
concentrated intcrtcrcnccs such as fatty acids and cholesterol in the 
case of samples such as whole blood Liquid-liquid extraction is one of 
the most useful tools that a chemist has for extracting a desired 
component from a mixture. Selective partitioning of the compound of 
interest into one of the two immiscible (or partially miscible) phases 
occurs by the proper choice of extraction solvents. Often, however, it 
is not possible to find the optimum conditions that provide both high 











recoveries may necessitate further extractions to achieve acceptable 
yields. In order to obtain an extract that contains as small an amount 
of impurities as possible, a second extraction procedure with a different 
solvent or pH may be required. Each successive step dilutes the 
sample further and also increases the extraction time. 
In recent years, interest in SPE has grown because it is rapid and 
efficient, thus permitting the use of small quantities of sample. It is also 
versatile as can be seen when back-extractions are required, where 
the analyst is able to switch from an organic to an aqueous solvent and 
then back to an organic solvent within minutes. This is not the case 
with LLE. 
The first reported use of SPE occurred in 1974 when Adams, Good 
and Telepchak accidentally dropped C18 packing material into a urine 
sample while working on high-performance liquid chromatography 
(HPLC) applications for clinical laboratories [21]. C18 packing material 
is composed of a silica backbone bonded with octadecane 
hydrocarbon chains. On testing the sample it was discovered that the 
steroids of interest were missing. Further testing revealed that the 
steroids were attached to the packing material, and only filtering, 
washing and re-suspending the packing material in methanol caused 
the steroids to be released for analysis [21]. 
The separation capability of gas chromatography (GC) combined with 
mass-selective (GC-MS) identification constitutes a powerful technique 
for doing routine toxicological analysis [21]. The sensitivity of these 
instruments, however, requires that the biological samples analysed be 
free from any matrix interferences. The challenge lies in developing a 
sample preparation method that provides sufficiently clean extracts 
from biological matrices such as whole blood and urine, and has the 
ability to extract a broad range of compounds. The need for a 
systematic approach to screening for drugs and poisons in biological 











influence of the sample matrices on the recovery and detectability of 
analytes has been pointed out by Bogusz et al [23]. SPE has been 
shown to be a powerful technique in this field of application [17, 18]. 
Most publications, however, focus on the extraction of single 
compounds or groups of related compounds. The development of 
mixed-mode solid-phase extraction allowed for the extraction of acidic, 
neutral and basic compounds in a single procedure using one column, 
thus enabling SPE to be used for screening purposes with good 
reproducibility [17-27]. Mixed-mode solid-phase extraction uses 
sorbents that consist of two or more bonding mechanisms in the same 
column. In order to obtain reproducible results, the process of SPE 
must be carried out carefully, especially when controlling the flow rates 
of the sample and the eluent during the extraction process. With the 
development of fully automated SPE procedures [17, 18, 29], 
reproducible and faster extractions became possible as operator 
interventions were no longer required during the process. 
Copolymeric bonded phases consisting of an ion-exchanger and a 
hydrophobic carbon chain attached to a silica backbone have been 
successfully used for the extraction of acidic, neutral and basic drugs 
[19-29]. Mixed-mode sorbents can be made by combining sorbents of 
each functional type, or they can be true copolymers in which different 
functional silanes are polymerized to the substrate. Copolymers 
typically give greater reproducibility, as no physical blending of phases 
is required [21]. Extraction columns containing these polymerized 
copolymeric phases have been successfully used to extract drugs from 
biological matrices [35]. Copolymeric sorbents have also been shown 
to give excellent recovery, reproducibility and selectivity and to be 
effective for the extraction of analytes from biological matrices [20, 36, 
37]. Inconsistent eluent flow rates, and hence inconsistent recoveries, 
are caused by the presence of smaller than average particles, or fines, 
in the mixture of silica-containing hydrophilic particles and ion-











1.10 AIMS AND OBJECTIVES 
The objectives of this study can be stated as follows: 
• To determine, through a study of the extent of drug and ethanol 
use, whether cases of unnatural death should be sent for drug 
screening on a routine basis. 
• To develop an efficient SPE method that is able to extract acidic, 
neutral and basic compounds from blood and urine, in a single, 
automated procedure. 
• To compare this SPE method with extraction methods currently 
being used atthe FCL CTN. 
• To validate this method on the basis of its specificity, accuracy, 
repeatability, intermediate precision, linearity of method, limit of 












MATERIALS AND METHODS 
2.1 BLOOD ETHANOL ANALYSIS 
This method involves the quantitative determination of the ethanol 
concentration of blood samples. Public pressure for the strict 
enforcement of laws that restrict driving under the influence of ethanol 
has resulted in a high demand for blood ethanol analysis. The current 
South African limit is 0.05 % (g/100 mt of blood). Headspace gas . 
chromatography is used internationally for the determination of blood 
ethanol and is the method used at the FCL CTN [32, 33]. The 
quantitative determination of ethanol in blood is performed using 
tertiary butyl alcohol (TBA) as internal standard [40, 41]. TBA is used, 
primarily because it is not a naturally occurring component of the blood 
samples analysed and the TBA and ethanol peaks are fully separated 
from each other in the chromatogram. Using an internal standard 
considerably decreases the requirements regarding the stability of 
temperature and eliminates the necessity of introducing equal volumes 
of the equilibrium gas into the gas chromatograph. The calculation of 
ethanol content is dependent on the internal standard response, which 
strengthens the validity of the result reported, provided the amount of 
TBA added is known and is determined reproducibly. 
2.2 BLOOD ETHANOL SAMPLE PREPARATION 
20 mt glass vials are prepared by labelling them for blank samples 
(water and internal standard), standards and samples, and by adding 
- 1 g of sodium fluoride to each vial to facilitate the migration of volatile 
components into the vapour phase according to Henry's Law [42]. The 











using a Hamilton Microlab 500 series dilutor, and dispensed into the 
marked vials [38, 43]. The vials are then capped with a rubber septum 
and crimped with an aluminium cap. Each sample is analysed in 
duplicate and the results are compared on a spreadsheet. 
2.3 REAGENTS FOR BLOOD ETHANOL ANALYSIS 
Standard ethanol in water solutions (10 mg/100 g, 20 mg/100 g, 
50 mg/100 g, 100 mg/100 g, 300 mg/100 9 and 500 mg/100 g) were 
supplied by the National Metrology Laboratory (NML) of the Council for 
Scientific and Industrial Research (CSIR). The sodium fluoride certified 
reference material (analytical grade) was also purchased from the 
NML. Tertiary butanol (99.5 % purity) and sodium sulphite were 
supplied by Merck (Darmstadt, Germany) and B & M Scientific 
respectively. Ultrapure water was obtained using the MiIIi-Q 
purification system at the FCL CTN. 
2.4 STANDARDS FOR BLOOD ETHANOL ANALYSIS 
The internal standard, 0.015 % TBA, was prepared by pipetting 150 j..Ir 
of TBA into a 1 r volumetric flask and diluting to the mark with ultrapure 
water. About 10 9 of sodium sulphite was also dissolved in this water 
to prevent traces of acetaldehyde being formed by the oxidation of 
ethanol. Standard solutions of ethanol in water at concentrations of 
10 mg/100 g, 20 mg/100 g, 50 mg/100 g, 100 mg/100 g, 300 mg/100 9 
and 500 mg/100 9 were used to draw up calibration curves. These 
curves were drawn by plotting the ethanol and internal standard peak 
area ratio against ethanol concentration. 100 mg/100 9 ethanol in 
water was used as a quality control standard and was run after every 
tenth sample during a run, to monitor the operation of the gas 
chromatograph. The sodium fluoride (NaF) standards were prepared 
in concentrations of 0.3 %, 1.0 % and 3.0 %, using water as solvent, 











2.5 INSTRUMENTS AND CONDITIONS FOR BLOOD ETHANOL 
ANALYSIS 
Hamilton Microlab 500 Series diluter 
The diluter that was used is controlled manually by the pressing of a 
button. It was programmed to perform each of the following steps: 
firstly, draw up 2 250 I-It of internal standard, then 10 I-It of air, followed 
by 250 I-It of the sample to be analysed; dispense 1 010 I-It into a 20 mt 
headspace vial and dispense the remaining 1 500 I-It to waste, to rinse 
the dispenser's tubing. Before a set of samples is pipetted, the analyst 
verifies that 1 mt of the blood sample and internal standard mixture is 
being dispensed consistently by the diluter. This is performed by . 
weighing five empty headspace vials and then dispensing ultrapure 
water into each of the vials. These vials are then weighed and the 
actual mass of the dispensed water is determined. By using the 
density of water, it can be established that the instrument is dispensing 
the correct volumes as programmed. In this study, the diluter was 
successfully verified by means of this procedure and then it was used 
to prepare the samples for analysis. 
Gas chromatographs with flame-ionization detectors, coupled to 
heads pace autosamplers (heads pace GCl 
Two gas chromatographs (GC1 and GC2) with headspace 
autosamplers, each fitted with a column of different polarity, were used; 
the results obtained by the two instruments were not allowed to differ 
by more than 10 %. 
The gas chromatographs used were both HP 5890 Series 2 
instruments. GC1 was fitted with a ZB Wax column (30 m x 0.53 mm x 
1.0 I-Im), and the temperature program was set at 35°C isothermal. 
The temperatures of the injector port and the detector were set at 
250°C and 255 °C respectively. GC2 was fitted with a DBALC-1 
Chromosorb column (30 m x 0.53 mm x 3.0 I-Im), and the temperature 











port and the detector were set at 250°C and 320 °C respectively. 
Nitrogen was used as the carrier gas at a pressure of 100 kPa for both 
instruments. Both autosamplers had the platen (a heated rack) 
temperature set at 65°C. The sample loop and transfer line 
temperatures were set at 85 °C and 100°C respectively, and the 
sample equilibration time was set at 30 minutes. Once the vials are 
taken into the platens, the headspace autosampler needles are used to 
take samples from above the sample liquids (the headspace), which 
are then injected onto the GC columns. 
Fluoride meter 
The fluoride meter used was a Eutech Cyberscan pH5500 dual-. 
channel ion meter. The tubes used for the collection of blood samples, 
contain sodium fluoride. It has been experimentally established that a 
sodium fluoride concentration of at least 1 % in blood samples inhibits 
the bacterial conversion of blood glucose to ethanol [41]. The sodium 
fluoride concentration of each blood sample was determined in order to 
verify that it was sufficient. The meter was calibrated using sodium 
fluoride standards with concentrations of 0.3 %, 1.0 % and 3.0 % 
respectively, after which the fluoride concentration of each sample was 
measured by placing the ion-selective electrode directly into the 
sample and recording the reading displayed on the screen. 
2.6 ANALYTICAL METHODS USED IN TOXICOLOGY 
2.6.1 CELITE EXTRACTION METHOD 
The Celite extraction method is used for cases in which no background 
information is supplied or a toxicology "screen" is requested. It is used 
to extract both drugs and pesticides from biological fluids. A piece of 
glass wool is placed in the tip of a plastic column, which is then placed 
in a vacuum manifold with a tube to collect the liquid beneath it. 750 !-It 
(or a different, known volume) of blood or urine is pipetted into a glass 











and then this mixture is stirred with a glass rod. Three drops of borate 
buffer (pH 9.2) are added and the mixture is stirred again. Two scoops 
of Celite powder are added and, after thorough mixing, the mixture is 
packed into the plastic column using the glass rod. Five to 10 mt of 
1-chlorobutane is added to the sample dish, to rinse the contents, and 
then added to the plastic column, which is eluted under vacuum. The 
eluent is evaporated to dryness under a stream of nitrogen and the 
residue reconstituted in 200 IJt of methanol (for drugs) or a hexane -
acetone - ethyl acetate (6:4:1) mixture (for pesticides). Once the 
residues have been reconstituted, they are ready to be analysed by 
gas or liquid chromatography. Analytical results based on this 
extraction are calculated as follows: 
inj vol std area sample d·l ~ d fmal vol sample 100 1100 I! --=------ X X 1 lactor x cone st x x = mg mt-
inj vol sample area std vol used 
inj vol std = injection volume of standard 
inj vol samp = injection volume of sample 
area sample = area of sample peak 
area std = area of standard peak 
2.6.2 BUTYL ACETATE EXTRACTION METHOD 
At the FCL CTN, this LLE procedure is used for the extraction of 
certain drugs of abuse from biological fluids. Liquid-liquid extraction 
(LLE), also known as solvent extraction, is a method used to separate 
compounds based on their solution preferences for two different 
immiscible liquids, usually water and an organic solvent. 
600 IJt of sample is placed in a plastic Eppendorf centrifuge tube. The 
sample is made alkaline by adding 50 IJt of ammonia and then mixed 
on a Clifton vortex for approximately 10 seconds. This step in the 
procedure ensures that basic drugs, such as most drugs of abuse, are 











vortexed for a further 60 seconds. The sample is placed in an 
Eppendorf centrifuge 5415 0 and centrifuged for 15 minutes at 13 000 
rpm. The top organic layer is isolated and used in the analysis. The 
concentration of each drug found and quantified using this procedure is 
multiplied by a factor of 0.25 to correct for the concentration step. 
2.7 REAGENTS FOR TOXICOLOGICAL ANAL VIS 
Preparation of iodide solution for Celite extractions 
A 0.5 M solution was prepared by weighing out 4.1 g of potassium 
iodide and making it up to a volume of 50 mt with distilled water. 1 mg 
of sodium thiosulphate was added per millilitre of iodide solution. The 
iodide solution was shaken with n-hexane in a separating funnel (ratio 
1:1) and allowed to separate. The aqueous phase was stored in a dark 
bottle. 
2.8 STANDARDS FOR TOXICOLOGICAL ANAL VIS 
Standards used for the quantification of compounds found positive 
during the study to inve tigate the extent of drug and ethanol use, were 
supplied by Industrial Analytical (Midrand, South Africa). Butyl acetate, 
ammonia and n-hexane (analytical grade) were supplied by Merck. 
The methanol was HPLC grade and was also supplied by Merck. 
Potassium iodide and sodium thiosulphate were supplied by Sigma 
Aldrich. Ultrapure water was obtained using the MiIIi-Q purification 
system at the FCL CTN. Separate stock solutions (1 mg/mt) of all 
compounds studied were prepared using methanol as solvent. The 
working standards were prepared by dilution of the stock solution with 
methanol. Solutions were stored at - 4 °C in the dark. A calibration 
curve based on five concentrations (each one of which was injected in 
triplicate) was obtained for each of the compounds identified on GC-
MS. The peak areas were plotted against the concentrations, which 











2.9 INSTRUMENTS AND CONDITIONS FOR TOXICOLOGICAL 
ANALYSIS 
Gas Chromatography - Mass-Selective Spectrometry (GC-MS) 
The GC-MS system consisted of an Agilent 6890N GC System, a 7683 
Series autosampler, a 76838 Series injector and a 5973 mass-
selective detector with electron-impact (EI) capabilities and a diffusion 
pump. An Agilent HP-1 MS capillary column (30 m x 250 I-Im x 0.25 
I-Im) was used for separation. The temperature program used was as 
follows: the oven was set at 60°C and increased to 320°C at a rate of 
25°C/min, and held for a further 10 minutes. The detector was a 
mass-selective detector (MSD) and a splitless-injection mode was used . 
with an injection volume of 1 I-It For single-ion monitoring (SIM) the 
dwell time per ion was 100 ms and the base peak area of each analyte 
was measured. A solvent delay of 3.8 minutes was used before the 
detector was switched on, to allow for the solvent used in the extraction 
process to pass the detector. Helium 6.0 was used as the carrier gas 
at a flow rate of 1 mt'min in the constant-flow mode and a pressure of 
56.7 kPa at an average velocity of 37 cm/s. 
The performance of the EI source of the instrument was monitored by 
performing an autotune, which is an automated source-optimization 
process of GC-MS systems, before each sequence. This was done to 
make sure that the source was free of water, that there were no leaks 
in the system and that the electron multiplier (EM) volts were at 
acceptable levels « 3000 EM volts). 
The column performance was monitored by analysing a known 
standard at the beginning and the end of each sample sequence, and 
checking for correct retention time and constant absorbance intensity. 
Gas Chromatography - Nitrogen-Phosphorus Detection (GC-NPD) 
The GC-NPD used was an Agilent 6890N instrument, which was set up 











two different columns that each went to a separate nitrogen-
phosphorus detector. In this way each compound detected on one 
column would be confirmed on another column with a different polarity 
while doing a single injection in one run. The columns used were a 
J&W DB-5MS column (30 m x 0.32 mm internal diameter) with a film 
thickness of 0.25 !-1m, and an Agilent Hewlett Packard 1 MS column 
(30 m x 0.32 mm internal diameter), also with a film thickness of 0.25 
!-1m. The injection mode was splitless with an injection volume of 3 !-It. 
The temperature program used for the detection and quantification of 
the drugs was the following: the initial temperature of 60°C was 
maintained for 1 minute and then raised at a rate of 20 DC/min to a final 
temperature of 280°C, which was maintained for 15 minutes. The 
injector was held at 250 °C and the detector at 280°C. 
2.10 DRUGS USED IN METHOD DEVELOPMENT 
The drugs chosen for the development of the SPE method in this study 
were: cocaine, imipramine, lorazepam, methamphetamine, oxazepam, 
phenobarbital, prazepam (internal standard) and secobarbital. These 
eight drugs, all of which can be detected on instrumentation currently 
available at the FCL CTN, were selected on the basis of positive 
identifications made during the study to determine the extent of drug 
use in Cape Town, and also because their pKa values cover a large 
range (1.3 to 11.6). The decision to take pKa values into consideration 
was necessary in order to ensure that the developed extraction method 
would be able to extract drugs of acidic, neutral and basic character. 
The structure, properties, uses and pharmacological effects of these 
drugs are given below. Following the convention of the Merck Index, 











Compound 1: COCAINE 
o 
pKa: 8.4; its principal mass spectral peaks are at m/z: 82, 182, 83, 105, 
303, 77, 94 and 96 [44]. 
Cocaine is considered to be the most potent of the naturally occurring 
central nervous system stimulants. It is found in the leaves of 
Erythroxylon coca, a plant that occurs in South America [45]. 
8enzoylecgonine is the major metabolite of cocaine and is present in 
urine specimens two to four days after use and may be found without 
detection of the parent drug if it is present in low concentrations. 
It is used therapeutically as a local anaesthetic, but is also used as a 
drug of abuse for its stimulant properties. It is normally used only as a 
surface anaesthetic in the eye, ear, nose and throat, because of the 
possibility of systemic toxic effects when given by other routes. Addicts 
may inject it or use it as a snuff; it is less toxic when taken orally, 
because of hydrolysis in the gastro-intestinal tract [45]. The estimated 
minimum lethal dose is 1.2 g, but susceptible persons have died from 
doses as small as 30 mg when applied to mucous membrane; addicts 











Compound 2: IMIPRAMINE 
pKa: 9.5; its principal mass spectral peaks are at m/z: 58, 235, 85, 234, 
236, 195, 193 and 208 [44]. 
Imipramine is the prototype of the tricyclic antidepressant drugs and 
has been among the most frequently used agents for the treatment of 
depression [47]. It has as its primary active metabolite desipramine, 
which accumulates in plasma and may account for much of the 
therapeutic effectiveness of the drug. Numerous instances of 
imipramine intoxication have occurred and at least 40 fatalities are 
recorded in the literature [45]. In adults the estimated minimum lethal 
dose is 1 g, although fatalities have occurred with less than this and 
patients have survived the ingestion of as much as 5 g [3]. 












pKa: 1.3 and 11.5; its principal mass spectral peaks are at m/z: 291, 
239,274,293,75,302,276 and 138 [44]. 
Lorazepam is a 3-hydroxy benzodiazepine, a group that includes 
oxazepam and temazepam [45]. Like many benzodiazepines that are 
administered in low doses, this drug is available as the free base in 0.5 
to 2 mg tablets, which necessitates its detection at very low 
concentrations [3, 21]. 
Lorazepam, like most benzodiazepines, is frequently prescribed for the 
symptomatic treatment of anxiety and sleep disorders [45]. 
Benzodiazepines were introduced in the 1960s and have replaced 
barbiturates for many indications. This drug has been classified as a 
date-rape drug along with y-hydroxybutyric acid (GHB), ketamine and 
flunitrazepam [3]. Lorazepam is rapidly conjugated with glucuronic 
acid, forming an inactive metabolite [45]. 
Compound 4: d-METHAMPHETAMINE 
pKa: 9.9; its principal mass spectral peaks are at m/z: 58, 91, 59, 134, 
65, 56, 42 and 57 [44, 45]. 
d-Methamphetamine (hereinafter referred to as methamphetamine), 
the N-methyl derivative of amphetamine, was first prepared in 1919 











The I-isomer is used as a decongestant in certain non-prescription 
inhalers such as Vicks inhaler. 
Methamphetamine is a potent central nervous system stimulant and is 
categorized as a phenylethylamine derivative. It has received a great 
deal of attention as a drug of abuse. lIicit methamphetamine is readily 
synthesized from phenylacetone and N-methylformamide (dl-mixture), 
or from ephedrine using acid reduction (d-isomer) [46]. 
Methamphetamine is also formed as a metabolite of benzphetamine 
and famprofazone [46]. 




pKa: 1.7 and 11.6; its principal mass spectral peaks are at m/z: 257, 77, 
268,239,205,267,233 and 259 [44]. 
Oxazepam is a metabolite of several benzodiazepines including 
chlordiazepoxide, clorazepate, demoxepam, nordiazepam, diazepam, 
ketazolam, medazepam, prazepam and temazepam. Since many 
benzodiazepines can yield similar metabolic products, identification of 
the parent compound is difficult. 
Oxazepam is the 3-hydroxy metabolite of nordiazepam and has been 











tablets or capsules containing 10 to 30 mg of the free base and is 
administered orally [44]. Because of the low doses in which 
benzodiazepines are prescribed, nanogram-per-millilitre concentrations 
must be detected. 
Oxazepam is rapidly conjugated with glucuronic acid and excreted in 
the urine, and only trace amounts of the free drug are found in the 
urine [45]. Glucuronic formation is a major metabolic route for 
benzodiazepines [21, 45]. 
Compound 6: PRAZEPAM 
a 
pKa: 2.7; its principal mass spectral peaks are at m/z: 91, 269, 324, 55, 
296, 295, 323 and 297 [44]. 
Prazepam is the N-cyclopropylmethyl analogue of diazepam. It was 
first synthesized in 1965 and is used in the treatment of anxiety [21, 
45]. 
Prazepam is either dealkylated to nordiazepam, the major plasma 
species, or oxidized to 3-hydroxyprazepam. This latter compound may 
be either conjugated directly or first dealkylated to oxazepam, which is 
then conjugated [45]. Adverse reactions to prazepam administration 
include dizziness, fatigue, drowsiness, weakness, confusion and 











Compound 7: PHENOBARBITAL 
pKa: 7.5; its principal mass spectral peaks are at m/z: 204, 117, 146, 
161,77,103,115 and118 [44]. 
Phenobarbital is a barbiturate derivative and has been used as a 
daytime sedative and very extensively s an anticonvulsant since 1912 
[45]. Barbiturates are central nervous system depressants and are 
potential drugs of abuse because of their hypnotic and sedative effects. 
The screening of urine for barbiturates is therefore widely practised. 
Toxic reactions to phenobarbital in chronically dosed subjects generally 
occur when plasma concentrations exceed 40 mg/t [45]. The classical 
measurement of phenobarbital in biological specimens involves 
ultraviolet spectrophotometry [45]; gas chromatography, however, 
provides a more specific result and is usually done with flame-











Compound 8: SECOBARBITAL 
H 
N 0- Na+ y 
N 
pKa: 8.0; its principal mass spectral peaks are at m/z: 167, 168,41,43, 
97, 124, 39 and 55 [44]. 
Secobarbital is a barbiturate derivative of short duration of action and 
was first prepared in 1934 [45]. Like many barbiturates, secobarbital is 
a potential drug of abuse because of its hypnotic and sedative effects 
[45]. During its metabolism and excretion, secobarbital undergoes 
extensive biotransformation by oxidation of both side-chains to a series 












EXTENT OF DRUG AND ETHANOL USE 
3.1 INTRODUCTION 
In this study the extent of drug and ethanol use in victims of unnatural 
death was investigated based on 601 deaths that occurred in Cape 
Town during the period from February to May 2005. The study 
population consisted of victims of unnatural death who presented to the 
Salt River and Tygerberg Forensic Pathology Laboratories, the two . 
mortuaries in Cape Town. Blood and, if possible, urine were sampled 
from each victim fitting the inclusion criteria. These were that the 
victims had to be ten years or older and had to have died of unnatural 
causes; furthermore, there had to have been no attempted 
resuscitation of the patient, so that no drugs other than those taken by 
the victims themselves would be detected. 
3.2 EXPERIMENTAL PROTOCOL 
The samples were taken out of storage at 5 °C and allowed to reach 
room temperature at about 25°C. 
The blood samples were analysed quantitatively for their ethanol 
content according to the procedure described in Sections 2.1 to 2.5. 
The blood and urine samples were extracted using the butyl acetate 
method described in Section 2.6.2; the extracts were then analysed by 
means of the procedures set out in the rest of Chapter 2. 
Urine from each case was sent to the National Health Laboratory 











tetrahydrocann(!binol, a component of c(!nn(!bis. (This (!nalysis was 
not performed at the FCL CTN at the t ime of the study.) 
3.3 RESULTS AND DISCUSSION 
The pathologists at the Salt River and Tygerberg Forensic Pathology 
Laboratories investigated 601 cases of unnatural death from February 
to May 2005. The manner of death was established (sec Figure 3.1) 
and samptes were provided for ana lys is. 
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Figure 3.1 Manner of death of the 601 cases tested 
Hom icide was found to be the leading manner of death. with 306 
victims of whom 106. or 35 %. tested posillve for the presence of 
drugs When the entire study populat ion of 601 is taken into account, 
the number of drug-posit ive cases was 172. which was 29 % of the 
tota l. 97 of these cases were pOSitive for more than one drug, giving a 
tota l of 163 occurrences of drugs for the ethanol-negative cases and 
135 for the ethanol-positive cases 
It can be seen from Figure 3.2 that. when the ethanol levels are 
grouped into intervals. the victims of unnatural death who were 
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Figure 3,2 Drugs related to ethanol level, based on the 164 drug-
positive cases for which ethanol results were obtained 
It is possible that many of these drugs would have remained 
undetected if the usual procedure had been fo llowed . This procedure 
involves routine testing for ethanol. but not for drugs. which are tested 
for only at the discretion of the pathologist. The most common drugs 
were found to be cannabis, diphenhydramine and methaqualone. 
which are frequently detected at the FCL CTN when drug analysis is 
performed. The extraction method used for the isolation of 
diphenhydramine and methaqualone (but not cannabis) has been the 
butyl acetate procedure and , as a result . only basic drugs have been 
detected. 
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Figure 3.3 Number of occurrences of drugs in ethanol-negative 











The number of occurrooces of the drugs mentioned in the pie charts of 
Figures 3.3 and 3.4 are based on 77 and 87 cases respectively. The 
negative sectors. on the other hand. represent 141 and 285 cases 
respectively. (Of the 601 cases. eleven could not be analysed for 
ethanol, because there was either insufficient or no blood sample.) It is 
clear that a significant proportion of the cases was negative for the 
presence of drugs, this trend being more noticeable in the ethanol-
positive cases Whether this is a true reflection of these victims' use of 
drugs or is a consequence of the limitations of the butyl acetate 
extraction procedure used . is not known. 
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Figure 3.4 Number of occurrences of drugs in ethanol-positive 
victims, based on 372 cases 
3.4 CONCLUSIONS 
Overall, the results of this study ind icate that the use of drugs remains 
a problem in Cape Town, and. more specifically. that there is a high 
prevalence of drug use among viclims of unnatural death Although 
cannabis and Mandrax (the active ingredients of which are 
methaqualone and, in most cases, diphenhydramine) were the two 
most common drugs found , the use of methamphetamine appears to 
be a growing problem in Cape Town: the FCL CTN detected this drug 
for the first time in December 2004, whereas in this study, which covers 
a period of only th ree months in the first half of 2005. there were 21 











In order to ensure that as many of these drug-positive post-mortem 
cases as possible are detected, it will be necessary for the pathologists 
to adopt a routine approach to drug screening, as is presently the case 
with ethanol. They must be supported by the FCL CTN with the use of 
effective and comprehensive extraction and detection methods. The 
results of this study provided the motivation to investigate, specifically, 
solid-phase extraction procedures, which are known to be capable of 
extracting a wide range of drugs, even when they are present at 
therapeutic levels, but which were not in use at the FCL CTN at the 
time of this study. The purpose of this work was, therefore, to make a 
contribution to the improvement of the service offered by the FCL CTN 












DEVELOPMENT OF SOLID-PHASE EXTRACTION 
METHOD 
4.1 WHAT IS SOLID-PHASE EXTRACTION? 
Solid-phase extraction (SPE), which is also known as sorbent 
extraction, is a physical process involving a liquid and a solid: the 
compound to be extracted is attracted more strongly to the solid phase 
than to the solvent in which it is dissolved. As the solution moves 
through the sorbent bed, the compound of interest is concentrated by 
the sorbent, whereas other compounds in the solvent pass through the 
bed. Highly selective extractions that produce very pure and 
concentrated extracts can be performed by choosing sorbents to which 
the desired compound, but not others in the solution, is attracted. The 
extraction efficiency and the quality of the separation are dependent on 
the physical properties of the sorbent, such as pore and particle size, 
as well as its chemical properties [19,21]. 
4.2 EXTRACTION MECHANISMS 
Sorbents are most commonly categorized by the nature of their primary 
interaction or retention mechanism with the analyte of interest. The 
three most common extraction mechanisms used in SPE are reversed 
phase, normal phase and ion exchange. 
4.2.1 REVERSED PH ASE 
Reversed-phase bonding, also called hydrophobic or non-polar 
bonding, occurs via attraction of non-polar groups to the sorbent by 
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Figure 4.1 Example of hydrophobic retention mechanism as a 
result of the preferred distribution of the less polar analytes to the 
similarly less polar stationary phase [36] 
Hydrophobic phases are alkyl chains and/or rings, with chain lengths 
from C2 to C18. Compounds are retained by non-polar interactions in 
the presence of polar solvents or matrix environments. Effective 
bonding also requires that the target analytes be in a neutral state. 
Elution, or disruption of the non-pol r interactions, is achieved by 
solvents or solvent mixtures with a sufficiently non-polar character. 
Some polar solvents such as acetonitrile have enough non-polar 
character to disrupt non-polar bonding and to cause elution of a 
compound from the sorbent. Methanol can be used as well, but it 
should be noted that it will elute both polar and non-polar analytes of 
interest as well as interferences [21]. 
The retention of an analyte on a reversed-phase sorbent is dependent 
on the equilibrium distribution between the solvent and the sorbent. 
For a particular analyte, it is the combination of sorbent and eluent 
properties that determines how efficiently the analyte is removed from 
the sorbent. 
Compounds that exhibit non-polar or neutral characteristics are 
extracted from biological matrices onto the sorbent by partition or 











partition mechanism, the analyte is transferred from the matrix to the 
sorbent, whereas in the adsorption mechanism, the analyte is not fully 
embedded in the sorbent, but is at the interface of the matrix and the 
sorbent. 
4.2.2 NORMAL PHASE 
Normal-phase bonding, also called hydrophilic or polar bonding, occurs 
by means of hydrogen bonding and/or dipole interactions. Compounds 
that are hydrogen donors, such as hydroxyls, carboxylic acids and 
amines, are characteristic of polar bonding (Table 4.1). 





Normal-phase retention mechanisms are commonly used to extract 
polar analytes from non-polar rganic solvents. These interactions are 
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Figure 4.2 Example of normal-phase retention mechanism 
These types of interactions occur when the distribution of electrons 
between individual atoms in functional groups is unequal, causing 











hydrophilic column include analytes that have polar groups. Analytes 
can be eluted by the use of relatively low concentrations of polar 
organic solvents such as methanol or isopropanol, in combination with 
non-polar organic solvents. 
4.2.3 ION EXCHANGE 
For an ion-exchange mechanism to occur, the sorbent must be 
composed of a silica backbone bonded with a carbon chain that is 
terminated by a positively or negatively charged functional group. lon-
exchange bonding mechanisms are electrostatic interactions between 
oppositely charged sorbents and analytes. Types of ion-exchange 
bonding mechanisms include cation-exchange, anion-exchange and 
copolymeric-exchange mechanisms. 
Charged sorbents are used to retain analytes of the opposite charge. 
For example, positively charged analytes containing amines are 
retained on negatively charged cation-exchange sorbents such as 
sulfonic acid or carboxylic acids. In contrast, negatively charged 
analytes containing sulfonic acid or carboxylic acid groups are retained 
on positively charged anion-exchange sorbents containing anyone of a 
variety of different amine groups. This is illustrated in Figures 4.3 and 
4.4. 
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Figure 4.4 Example of anion-exchange retention 
Only species of the proper charge are retained by the column, so most 
matrix contaminants are simply rinsed away to waste during the 
loading and washing steps. For this reason, cation-exchange SPE is 
commonly used for the extraction of basic compounds (drugs and other 
amine-containing compounds) from complex biological samples. The 
bonding can be reversed by changing the pH conditions or by 
introducing competing ions with greater sorbent affinity than the 
compounds of interest, which results in displacement of the analyte. 
pH and pKa play an important role in ion-exchange extraction 
procedures. The most significant factors in ion-exchange 
chromatography are the pKa of the analyte, the sorbent, the pH, the 
ionic strength of the mobile phase, and the acid-base properties of the 
typical functional groups on the sorbent as well as the target analyte. 
The pKa is the pH at which 50 % of the molecules are protonated and 
the other 50 % are deprotonated. The quantitative ionization or 
neutralization (99.5 %) of a functional group occurs at a pH value 2.0 
units above or below the pKa [20]. These relationships are described 











pKa = -loglO Ka, where Ka = [H+][A-] with HA being an acid and A- the [HA] 
conjugate base. The relationship between pKa and pH is given by the 
equation pH = pKa + loglO ([ba~e ]). When the pH is equal to the pKa, 50 
[acId] 
% of the acid is protonated. 
For example: the pKa of a typical carboxylic acid is 4, and so the weak 
acids are charged at pH 6 and non-ionized (neutralized) at pH 2 [21]. 
At a pH of 4, 50 % of the molecules are protonated and non-ionized, 
and the other 50 % are ionized (charged). Consequently, low recovery 
values would be expected for carboxylic acid analytes on anion-
exchange sorbents at pH 4 or below. In contrast, at pH 6, 
approximately 99.5 % of the analytes would be ionized and retained. 
Similarly, weak amines, such as most drugs of abuse, all tend to have 
fairly similar acid-base properties, even though minor differences do 
exist between secondary (2°) amines relative to primary (1°) and 
tertiary (3°) amines [21]. In general, weak amines have pKa values of 
approximately 10, and are charged (and retained on cation-exchange 
sorbents) at pH 8 and non-ionized (and eluted) at pH 12. Elution 
occurs by using a solvent to raise the pH above the pKa of the cationic 
group or to lower the pH below the pKa of the anion to disrupt retention. 
At this point, the sorbent or compound will be non-ionized (neutralized). 
4.2.4 COPOLYMERIC BONDING 
Copolymeric sorbents have both hydrophobic and ionic-retention 
mechanisms. They consist of silica backbones with both reversed-
phase and ion-exchange functionality and can therefore be used for the 











4.3 SOLID-PHASE SORBENTS 
4.3.1 SORBENT PROPERTIES 
Solid-phase sorbents are available in a wide range of surface 
chemistries, pore sizes (60, 120,200 and 300 A), particle sizes (10,40, 
100 and 150 I-Im), and base supports (silica, alumina and polymers) 
[20,21]. 
The optimal sorbent for any given extraction problem is dependent on 
the properties of the target analyte, the sample/matrix composition and 
other factors, which are discussed below [21]. 
4.3.2 SORBENT SPECIFICITY 
Theoretically an "ideal" solid-phase sorbent binds only the target 
analyte(s), resulting in a contaminant-free eluent. In practice, however, 
the analysis is influenced by the retention of the target analytes as well 
as many contaminants, but the effect of contamination may be 
counteracted by the concentration of analytes on the sorbent and by 
properly optimized extraction conditions [20, 22]. It is therefore vital for 
the sorbent chemistry to be selected with care and for the extraction 
conditions to be optimal. Sorbent specificity is a function of the 
extraction conditions as much as of the surface chemistry, and the 
sample-loading conditions can even determine the chromatographic 
technique that will be used to analyse the extract [20, 33, 36]. 
4.3.3 SILICA-BASED SORBENTS 
Silica-based sorbents are rigid, stable and relatively inexpensive, and 
they do not shrink or swell in most aqueous and organic solvents. 
Furthermore, it is easy to derivatize and manufacture them 
reproducibly. Those that are most widely used consist of chemically 
modified silica particles with covalently attached functional groups on 
the surface. Chromatographic selectivity can by significantly altered by 
modifying the silica surface. Unfunctionalized silica, for example, 











means of normal-phase and cation-exchange mechanisms, to being 
non-polar when a C18 saturated hydrocarbon is attached to the 
surface. Sorbents possessing various separation selectivities can be 
achieved by covalently attaching appropriate functional groups [19, 20, 
36]. 
Silica-based sorbents may, after the initial bonding reaction, still 
contain a residual amount of unreacted -Si(OH) groups. These "free" 
groups constitute polar and acidic areas on the sorbent surface that 
can bind amines by means of hydrogen bonding and cation-exchange 
mechanisms. Interaction with these groups can lead to unwanted 
retention and low recoveries, because some analytes are ionized 
during extraction. The -Si(OH) groups are therefore methylated, 
usually with trimethylsilyl (TMS) groups, in a reaction known as 
endcapping [19, 20,36]. 
4.3.4 POLYMERIC SORBENTS 
Polymer-based sorbents typically consist of highly cross-linked 
polystyrenedivinylbenzene (PSDV8). Unlike unfunctionalized silica, 
PSDV8 is non-polar and is capable of strong hydrophobic and TT-TT 
interactions with non-polar and electron-rich analyte molecules [19-21]. 
4.3.5 COPOLYMERIC SORBENTS 
This sorbent is composed of a silica backbone with two types of 
functional chains attached: an ion-exchanger (or polar) chain and a 
hydrophobic carbon chain. It is produced in a way that allows for equal 
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Figure 4.5 Example of a copolymeric sorbent (anion-exchange 
phase) [47J 
Such sorbents are referred to as -mixed-mode" sorbents, Th is type of 
dual chemistry is beneficial. especially if one is cxtractlng both a 
neutral and a charged compound ThiS is common when a neutral 
parent drug is metabolized and DeCOmeS charged [19, 20], 
A sorbent containing both cation-exchange and non-polar 
functionalities is optimal for extracting small alkaline compounds with a 
moderate degree of hydrophobicity, since such compounds can be 
retained by both moderately strong non-polar interactions and by cation 
exchange Opiates, Denzodlazepines and tricyclic antidepressants fall 
into this categol)' [19-21], One such sorbent exhibits hydrophobic 
properties (Decause of a non-polar carbon chain) and cation-exchange 
properties (because of a benzenesu lfonic acid functiona l group, which 
















Benzenesulfonic acid is considered to be a strong cation exchanger 
[19-21]. The drugs encountered in forensic samples are mostly weakly 
basic, thus easily forming anions dependent on the matrix pH. 
Benzenesulfonic acid, which is a strong acid, was therefore chosen as 
the ion exchanger on the sorbent. 
This mixed-mode mechanism facilitates the isolation of acidic/neutral 
and basic drugs and can be performed in a single extraction using a 
single column, since the sorbent is composed of a silica backbone with 
an ion exchanger and a hydrophobic carbon chain. Depending on the 
pKa of the metabolite, amine-containing groups may be positively 
charged, allowing the metabolite to bond to the negatively charged 
sorbent. Since the column also possesses a hydrophobic chain, the 
neutral parent drug is able to bond to the column. 
4.4 STEPS IN SOLID-PHASE EXTRACTION PROTOCOLS 
Sample preparation in SPE typically consists of four steps: 
conditioning, sample loading, washing and analyteelution. Because 
SPE takes advantage of the same physicochemical interactions used 
in HPLC, the recovery and purity of the target analyte(s) can be 
optimized by adjusting the composition of the solvents used during 
each of the steps (sample loading, washing and analyte elution) listed 












Table 4.2 The four basic steps of an SPE procedure 
(Modified from [21]) 
purpose 
To prepare the sorbent for effective and reproducible interaction 
conditioning 
with the analyte(s) by solvation. In effect, solvation is a wetting 
of the sorbent, creating an environment suitable for analyte 
retention. This is followed by equilibration in a solvent similar to 
the sample/matrix. 
sample/matrix To vary the sample/matrix composition in a way that leads to 
pre-treatment retention of the analyte(s) while keeping impurities to a 
and loading minimum. 
To remove impurities that are not as strongly bound to the 
washing 
sorbent as the analyte(s). 
To disrupt functional bonding mechanisms and selectively 
analyte elution 
release compounds for collection and analysis. 
4.5 METHOD DEVELOPMENT AND OPTIMIZATION 
An extraction method was developed using the CLEAN SCREEN® 
DAU and the larger-particle, Xtrackr® columns, from United Chemical 
Technologies Inc (Pennsylvania, USA). These columns contain a 
copolymeric silica extraction support consisting of hydrophobic chains 
(octylsilane, n-C8) and strong cation-exchange moieties 
(benzenesulfonic acid) that have the ability to retain acidic, neutral, 
basic and amphoteric drugs on one column. 
In this study, the method followed was based on several reported 
procedures in the literature for the extraction of drugs from biological 
materials [21, 23, 28, 34, 36, 37, 48]. It was then further modified to 
improve detection and recovery by the careful selection of solvents and 
by choosing the appropriate sorbent particle size. Capillary gas 
chromatography with fused-silica capillary columns and nitrogen-











the analysis of underivatized drugs in biological extracts, and it was 
therefore used in this study. Since many drugs contain nitrogen, traces 
of them can be selectively detected with minimal interference from non-
nitrogenous compounds, both endogenous and exogenous [49]. Ge-
MS with single-ion monitoring was employed for quantitative and 
qualitative analysis of the spiked compounds based on the diagnostic 
mass spectra of the analytes; the base peaks were used for 
quantification. Although this method was developed using urine, it was 
also intended to be used for the extraction of drugs from other body 
fluids as well as tissue [50-52]. 
The first step in developing an effective SPE method is the choice of 
the most appropriate retention mechanism and of the sorbent. The 
main considerations in the sorbent selection process are the physical 
nature of the sample/matrix, the chemical structure of the analyte, and 
the unique selectivity and specificity properties of each individual 
sorbent [53]. As the extraction method was required to extract a range 
of drugs with varying pKa values during a single extraction procedure, a 
combination of separation strategies was needed. A copolymeric 
bonded phase was therefore selected for this purpose. 
4.5.1 EFFECT OF SAMPLE APPLICATION pH ON COMPOUND 
RETENTION 
There are three possible mechanisms of interaction between a sorbent 
and any compound, namely adsorption, hydrophobic and ion 
exchange. The application pH affects the retention and recovery of a 
drug. When a sample containing the drugs chosen for this study is 
prepared, phosphate buffer at pH 6.0 is added and loaded onto a 
copolymeric column. The basic drugs - cocaine, imipramine, 
methamphetamine and secobarbital (the pKa's of which are 8.4, 9.5, 
9.9 and 8.0 respectively) - are almost fully ionized at this pH. The 
average pKa for these drugs is 9.0. Therefore, at the pH of 9, 50 % of 
the drugs are protonated (neutral) and the other 50 % are ionized. The 











the cation-exchange part of the sorbent at pH 6.4. At pH 10.4, the 
molecule is protonated/neutral and can be eluted. The pKa of 
imipramine is 9.5 and it is therefore charged and retained at pH 7.5 and 
neutral at pH 11.5. The pKa of methamphetamine is 9.9, which means 
that it is charged at pH 7.9 and can be eluted at pH 11.9, when it is 
protonated. At the application pH of 6, cocaine, imipramine, 
methamphetamine and secobarbital are all fully ionized and would be 
retained by the sulfonic acid moiety of the sorbent. The pKa of 
secobarbital is 8.0 and it is therefore charged at pH 6.0 and neutral at 
pH 4.0, and will bind to the cation-exchange part of the sorbent through 
electrostatic bonding. The secobarbital molecule, however, also has a 
significant non-polar portion that would be attracted to the hydrophobic. 
part of the sorbent. 
At the same application pH of 6.0, of the acidic drugs in the sample -
lorazepam, oxazepam and prazepam, the pKa's of which are 1.3 and 
11.5, 1.7 and 11.6, and 2.7 respectively - only prazepam is fully 
ionized. Since the sorbent does not contain any anion-exchange 
groups, these compounds cannot bind to the column via this 
mechanism and, in contrast to the binding mechanism of the basic 
compounds, the neutral or non-polar parts of the acidic drugs are 
attracted to the hydrophobic chains on the sorbent. 
4.5.2 EFFECT OF ELUTION SOLVENT ON COMPOUND 
RETENTION 
The column properties make provision for the effective retention of 
acidic, neutral and basic compounds, but it is also necessary to elute 
the compounds from the column selectively. The polarity of the solvent 
used to elute each compound from the column becomes critical (Figure 
4.7). The elution solvent strength should be the weakest solvent that 
completely disrupts all binding mechanisms of the analyte as needed 
(hydrophobic, polar, and/or ion exchange). For each drug, the energy 
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Figure 4.7 Solvent polarity and elution strength [21] 
Acidic/neutral compounds and analytes that are hydrophobically bound 
can be removed using organic solvents of minimal polarity such as the 
hexane and ethyl acetate mixture (50:50 v/v), which can elute the 
hydrophobically bound analytes. On the other hand, cationic 
compounds and many others with intermediate polarity, including 
potential interferences, will remain bound to the column. Most of the 
potential interferences that are not ionically bound can be removed by 
means of a methanol wash. The effective elution of cationic analytes is 
achieved by applying an organic solution with a high pH, such as the 
methylene chloride - isopropanol - ammonium hydroxide mixture 
(78:20:2 v/v). The eluting strength and the pH of this solvent mixture 
are appropriate for these compounds. The methylene chloride -
isopropanol - ammonium hydroxide mixture simultaneously disrupts the 
ionic interactions and successfully elutes the cationic compounds. The 
key principle that applies here is that "like dissolves like", which is 











Drying is performed before each elution step, under full vacuum or 
positive pressure (in the case of positive-pressure manifold or 
automated extraction systems), in order to remove all traces of residual 
sample/matrix and wash solvent, especially those that are immiscible 
with water (for example, hexane, ethyl acetate and methylene 
chloride), from the sorbent. This produces a more concentrated final 
extract with a constant volume and composition, and ensures better 
reproducibility and higher recoveries. See Appendix 2 for the details of 
the extraction method. 
4.6 EXPERIMENTAL 
4.6.1 DRUG STANDARDS AND CHEMICALS 
A series of acidic/neutral and basic drugs was used to investigate the 
effect of the pH of sample application on isolate retention and 
subsequent recovery. Cocaine, imipramine, lorazepam, 
methamphetamine, oxazepam, prazepam, phenobarbital and 
secobarbital were obtained as drug standards from Industrial Analytical 
(Midrand, South Africa). 
CLEAN SCREEN® DAU (200 mg, 3 m! capacity) and Xtrackr® 
(200 mg, 3 m! capacity) copolymeric extraction columns were provided 
by PM Separations (Brisbane, Australia). The Caliper RapidTrace 
automated SPE system and the TurboVap evaporator were purchased 
from Microsep. HPLC grade solvents and reagent grade chemicals 
were obtained from Merck. 
The analytes were purchased at a concentration of 1 mg/mt Individual 
stock solutions of 1 00 ~g/m! were prepared by mixing 1 00 ~! of each 
pure compound with 900 ~! of methanol. These stock solutions were 
stored in glass vials at 4°C. Appropriate dilutions with methanol 
yielded the working solutions of the compounds used in the study. 











which concentrations and responses could be compared. The 
presence of prazepam in urine has never been reported and only trace 
amounts of nordiazepam, its major metabolite, have been found [45]. 
4.6.2 PREPARATION OF SPIKED URINE SAMPLES 
Blank urine samples collected from two subjects were combined and 
analysed for the presence of interferences. A mixture of drug 
standards was prepared by combining 100 IJl of cocaine, imipramine, 
lorazepam, methamphetamine, oxazepam, phenobarbital and 
secobarbital respectively (each at 1 mg/ml) in a vial and diluting to 1 ml 
with methanol, giving a concentration of 100 IJg/ml for each standard .. 
100 IJl of this solution was added to 900 IJl of the blank urine sample, 
which yielded a solution with a concentration of 10 IJg/ml for each of 
the seven drugs. 500 IJl of the 1 mg/ml prazepam solution (internal 
standard) was added to 49.5 ml of a phosphate buffer solution, giving a 
prazepam concentration of 10 IJg/m!. 
4.7 EXTRACTIONS 
4.7.1 INVESTIGATION OF CLEAN SCREEN® DAU COLUMN 
(200 mg, 3 ml capacity) 
Clean Scree ® DAU columns were conditioned with methanol (3 ml), 
deionized water (3 ml) and 0.1 M phosphate buffer (pH 6; 1 ml). The 
sample (1 ml) was buffered to pH 6 and added to the sorbent at a rate 
of 1 to 2 mYmin. The column was washed with deionized water (3 ml) 
and 0.1 M acetic acid (1 ml). After drying the column for 5 minutes, the 
sorbent was rinsed with hexane (2 ml). The acidic/neutral drugs were 
then eluted with hexane - ethyl acetate (50:50 v/v; 3 ml) after which the 
column was washed with methanol (3 ml) and again dried for 5 
minutes. The basic drugs were eluted with dichloromethane - isopropyl 
alcohol - ammonium hydroxide (78:20:2 v/v; 3 ml). The extracts were 











reconstituted in ethyl acetate (100 !-It, acidic/neutral fraction) and 
methanol (100 !-It, basic fraction) prior to analysis by GC-NPD and Ge-
MS. 
4.7.2 INVESTIGATION OF XtrackT® COLUMN (200 mg, 3 me 
capacity) 
The extraction procedure described above was carried out, with the 
spiked mixture also being applied at pH 6.0, but using the Xtrackr® 
column, which has a larger particle size. The extracts were evaporated 
to dryness at < 40°C under a stream of nitrogen, and reconstituted in 
ethyl acetate (100 !-It, acidic/neutral fraction) and methanol (100 !-It, 
basic fraction) prior to analysis by GC-NPD and GC-MS. 
4.7.3 INVESTIGATION OF DIMETHYL FORMAMIDE AS "KEEPER" 
SOLVENT 
Certain compounds such as amphetamines and phencyclidine are heat 
labile, and care should be taken not to overheat or over-evaporate the 
samples when such drugs are present. In forensic samples, however, 
it is not always known what drugs are present in a sample and 
derivatization is therefore required. 40 !-It of dimethyl formamide 
(DMF), a "keeper" solvent [45], was added to the elute of the basic 
fraction of the spiked urine to reduce the loss of the heat-labile 
compounds caused by their volatile nature. Such loss can occur during 
the evaporation stage or in the injection port of the GC-NPD or GC-MS 
when the extract is injected [54]. DMF solubilizes the analyte and 
promotes conditions that improve the reaction yield. It is not a very 
volatile organic solvent and acts to dissolve the drugs in an 
environment that has a higher boiling point than that of the drugs 












4.7.4 INVESTIGATION OF THE EXTRACTION EFFICIENCY OF 
THE FCL CTN IN-HOUSE METHODS COMPARED TO THE 
XtrackT'!! COLUMN SPE METHOD 
The butyl acetate and Celite extraction metoods were compared to Ihe 
XlrackT'" column SPE method The same sample. namely urine spiked 
with the eight drugs, including the internal standard, each at a 
concentration of 10 lJg/ml was used for each extraction procedure . 
OMF W<lS added to the elute of the basic fraction of the SPE S<lmple 
The extracts were an<llysed on GC-MS with single-Ion monitoring. <lnd 
the Ions for each compound were extracted (a term used to describe 
selecling specific ions out of a chromatogram) and the areas under the 
base peaks were compared with those from the other extraction 
techniques The base peak of a compound refers to the most Intense 
ion. which is assigned an abundance of 100. Figures 4.8 to 4.14 show 
the fragmentation patterns obtained for the respective compounds, with 
the b<lse pe<lk soowlng the highest abundance. 




Figure 4.8 GC·MS chromatogram (of selected ions) of the 











Figure 4.9 GC·MS chromatogram (of selected ions) of the 
imipramine standard (200 1J9Im~), with the base peak at 58 m/z 
""~ , " 
.w .. , 
, ~" 
o 
figure 4.10 GC-MS chromatogram (of selected ions) of the 
lorazepam standard (30 1J9/m€), with the base peak at 239 m/z 
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figure 4.11 GC·MS chromatogram (of selected ions) of the 
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Figure 4.12 GC-MS chromatogram (of selected ions) of the 
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Figure 4.13 GC·MS chromatogram (of selected ions) of the 
phenobarbital standard (200 Ilglme), with the base peak at 200 m/z 




Figure 4.14 GC-MS chromatogram (of selected ions) of the 











4.8 RESULTS AND DISCUSSION 
4.8.1 CLEAN SCREEN"" DAU COLUMN (200 mg, 3 me capacity) 
The ana lyles retained by the hydrophobic groups of the sorbent woro 
eluted using the moderately poi<Jr solvent combination of hexane and 
ethyl acetate. The chromatogram is shown in Figure 4.15. 
Figure 4.15 GC-NPD chromatogram of the acidiclneutral fraction 
from urine spiked with 10 jJg/me of the test mixture, and extracted 
from the CLEAN SCREENi!l DAU column (2: imipramine, 3: 
lorazepam, 5: oxazepam, 6: prazepam (internal standard), 7: 
phenobarbital, 8: secobarbital) 
The drugs with pKa values of 80 or less - lorazepam. oxazepam 
phenobarbital, prazepam and secobarbital - were all extracted 
predominantly in the acidic fraction. Imipramine (Compound 2) was, 
however. only partially extracted with th is elution solvent 
The basic analytes retained by the cation-exchange groups of the 
sorben! were eluted by using the ammoniated dichloromethane and 
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Figure 4.16 GC·NPO chromatogram of the basic fraction from 
urine spiked with 10 IJglm~ of the test mixture, and extracted from 
the CLEAN SCREEN"' OAU column (1: cocaine, 2: imipramine, 6: 
prazepam (internal standard) 7: phenobarbital, 8: secobarbital} 
Only imipramine (pK, 9_5) and cocaine (pK, 84) were retained, wilh 
partial extractions of secobarbital phenobarbital and prazepam 
occurring I'Jith this eluent. Methamphetamine was not, however, 
detected by GC-NPD in the basic fraction of the extraction procedure 
involving the CLEAN SCREEN'" DAU column, as can be seen by the 
absence of a peak at the retention time of 9,2 minutes. The internal 
standard (prazepam), however, eluted only in the acidiclneutral fraction 
and not in the basic fraction during the extraction process_ As a result 
the ratios for analyte to internal standard response could not be 
calculated for all the compounds in both fractions The calculated 
recoveries during the method development stage were therefore based 
on external standards only and are thus only a rough estimate of the 
recovery potential of the ex.traction columns, 
4.B.2 XtrackT'" COLUMN (200 mg, 3 me capacity) 
Figure 417 shows that lorazepam, ox.azepam , 
prazepam and secobarbital were, as with the CLEAN 
phenobarbital, 
SCREEN'" DAU 



















Figure 4.17 GC-NPD chromatogram of the acidic/neutral fraction 
from urine spiked with 10 Ilglmf: of the test mixture, and extracted 
from the XtrackT" column (3: lorazepam, 5: oxazepam, 6: 
prazepam. 7: phenobarbital, 8: secobarbital) 
.No major differences were observed in the extraction capab ilities 
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Figure 4.18 GC·NPD chromatogram of the basic fraction from 
urine spiked with 10 IJglm€ of the test mixture and extracted from 
the XtrackT'" column (1: cocaine, 2: imipramine, 4: 
methamphetamine, 5: oxazepam, 
6: prazepam (internal standard), 7: phenobarbital, 8: secobarbital} 
The elution fraction containing the basic drugs is shown in Figure 4.18. 
At the appl ication pH of 6.0 cocaine, imipramine and 











consequently well retained on the column, The ammoniated 
dichloromethane and IPA solvent mixture was able to doprotonate the 
drugs and thereby displace them . Methamphetamine (Compound 4) 
was, however. only part ially detected in th is elution fraction 
4.8.3 DIM ETHYL FORMAMIDE AS "KEEPER" SOLVENT 
The addit ion of the' keeper" so lvent DMF to the elute of the basic 
fract ion (Figure 4. 19) of the extract prevented the volaWe components 
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Figure 4.19 GC-NPD chromatogram of the basic fraction from 
urine spiked with 10 tJg1me of the tes t mixture and ext racted from 
the CLEAN SCREEN'"' DAU column w ith DMF added (1: cocaine. 2: 
imi pramine. 4: methamphetamine, 6 : prazepam (internal 
standard), 7: phenobarbital , 8: secobarbi tal ) 
Fol lOWing the addition of DMF to the basIc fraction extracts. the 
methamphetamine was detected after use of the CLEAN SCREEN'" 
DAU and the XtrackT'" columns, The other basic components, cocaine 
and imipramine, also showed increased recoveries, These increases 
were , however, more noticeable with the Xtrack-r' co lumn (Figures 
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Figure 4.20 GC-NPD chromatogram of tho basic fraction from 
urine spiked with 10 IJglm€ of the test mixture and extracted from 
the XtrackT" column with DMF added (1: cocaine, 2: imipramine, 
4: methamphetamine. 6: prazepam (internal standard), 7: 
phenobarbital, 8: secobarbital) 
Although the urine sample was spiked with methamphetamine before 
the initial extractions , there WClS no indiCCllion of Its presence when the 
CLEAN SCREEN " DAU co lumn was used and only a small peak when 
the XtrackT" column was used The addition of DMF improved the 
yield of metham phetamine and the other basic drugs in the extraction_ 
the methamphetamine peak is now present in the CLEAN SCREEN'" 
DAU chromatogram, and methamphetamine as well as cocaine and 
imipramine all show a higher abundance on the XtrackT" column 
(Figures 4.19 and 4.20). 
4.8.4 THE EXTRACTION EFFICIENCY OF THE FCL CTN IN-
HOUSE METHODS COMPARED TO THE XtrackT·;· COLUMN 
USING THE SPE METHOD 
The XtrackT'" SPE procedure was compared with the butyl acetate and 
Cel ite methods currently in use at the FCL CTN. Urine samples were 
spiked at 10 IJglml. in trip licate. for each method. extracted and 
analysed on GC-MS using single-ion monitoring (SI M). For this 
experiment. the internal standard was added to the extracted fract ions 











area under each of the base peaks for Ihe spiked and exiractcd urine 
samples was measured, for the three extraction methoos. The reSll lts 
of the comparative study are su mmarized in Table 4.3 and Figure 4.21 
Table 4.3 Comparison of FCL CTN and SPE methods using 
extracted base-peak ions analysed on GC-MS SIM 
--
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drug t ime ,K. peak % % 
(min) recovery 
average recovery 
(n = 3) recovery (n'" 3) 
(n .. 3t. , coca ine eM eo " , 104.7 39.9 74.5 --_. ,. imi ramine 905 9,5 " 102.6 39.5 82,5 , loraz~am 9,67 1.]/ 11.5 no 23.0 19. 3 '" 
4. methamphetami ne 4,27 "' " 99,9 65.5 
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Figure 4.21 Results of the comparison of the extraction 
efficiencies of the SPE . Celite and butyl acetate procedures {1: 
cocaine, 2: imipramine, 3: loral:epam, 4: met hamphetamine, 5: 
oxazepam, 6: phenobarbital, 7: secobarbital) with error bars 
















The butyl acetate extraction method was able to extract all the drugs 
except secobarbital, its highest extraction recovery being that of 
methamphetamine at 65.5 %. The Celite method gave extraction 
recoveries of between 58 % and 82 %, but it was not able to extract 
lorazepam, methamphetamine or oxazepam. The SPE method was 
able to extract all the spiked drugs with recoveries of between 23 % 
and 104 %. The Celite and SPE methods yielded similar extraction 
recoveries for phenobarbital and secobarbital. 
4.9 CONCLUSIONS 
These experimental results show that factors such as the functional 
groups of the extracted compounds at given pH values, the pKa values 
and the compound polarities need to be considered when determining 
the application pH and strength of eluents. The mixed-mode sorbents 
allowed the acidic/neutral compounds (Iorazepam, oxazepam, 
phenobarbital and prazepam) to adsorb onto the column mostly 
through hydrophobic attractions. Similarly, the basic compounds 
(cocaine, imipramine, methamphetamine and secobarbital) were held 
predominantly through ionic but also some hydrophobic attractions at 
the application pH of 6.0. The CLEAN SCREEN® DAU and Xtrackr® 
columns were equally effective at extracting all the spiked drugs, since 
the sorbent properties of both columns are similar, although the 
Xtrackr® column has a slightly larger particle size. The low recoveries 
of oxazepam and lorazepam could be due to their limited solubility in 
water [36]. In real samples, however, a common route of 
biotransformation for benzodiazepines is conjugate formation in which 
the drug combines with a neutral sugar to form a glucuronide [36]. 
These samples must consequently be deconjugated before analysis, 
and chemical derivitization is required for better detection and 
confirmation results [36]. 
In order to elute the basic drugs, the ionic and hydrophobic interactions 











non-polar organic solvent containing ammonium hydroxide so that the 
pH of the eluent was alkaline. The charges on the basic drugs were 
neutralized by the pH of the eluent, which allowed them to be removed 
from the sorbent easily. Methamphetamine was successfully 
recovered from the sorbent by the addition of IPA to the eluent, thereby 
increasing the polarity of this relatively polar drug and hence increasing 
its solubility. 
The addition of the "keeper" solvent DMF to the basic fraction of the 
eluent to minimize the evaporative loss of the heat-labile compounds, 
improved the recovery not only of methamphetamine, but also of 
cocaine and imipramine. The only difference in the extraction of the . 
spiked urine samples on the two columns resulted from the addition of 
DMF, which led to a greater recovery of the basic drugs using the 
Xtrackr® column compared to the CLEAN SCREEN® DAU column. 
Overall, the SPE method using the Xtrackr® column gave the best 
extraction recoveries and was also the only method to isolate all the 
spiked drugs, and this method was therefore chosen to be validated. 
Validation was necessary in order to determine the method's suitability 
for routine use. It was, however, observed during the method 
development process that the addition of prazepam as an internal 
standard to the urine sample prior to extraction, resulted in prazepam 
being eluted only in the acidic fractions of the extraction process. It 
was therefore not possible to compensate for variations in the 
extraction process for all the drugs in the SPE process. As a result of 
this observation, the comparative study was performed with prazepam 
being added to the eluted fractions of the SPE method, as well as for 
the butyl acetate and Celite methods, before drying and reconstitution. 












VALIDATION OF THE SPE METHOD 
5.1 VALIDATION PROCEDURE 
Validation is the process by which it is established, by means of 
laboratory studies, that the performance characteristics of a test meet 
the requirements for the intended analytical application. The process 
also establishes the limitations of the test as well as any influences that 
may change these characteristics, and to what extent. The following 
criteria were used for the validation of the SPE method: specificity, 
accuracy, precision, linearity of method, limit of quantification and limit 
of detection. The validation process was performed using urine as the 
matrix and it was spiked with cocaine, imipramine, lorazepam, 
methamphetamine, oxazepam and phenobarbital. These drugs were 
extracted on Xtrackr® columns. Prazepam was used as an internal 
standard and was added to the extracted acidic and basic fractions 
before the drying and reconstitution steps in the method. DMF was 
added to the basic fraction to prevent evaporation of the volatile 
analytes. Detection and quantification of the spiked compounds of 
both the acidic and basic fractions were performed by GC-MS with 
single-ion monitoring. 
As the developed SPE method was based on recommended 
techniques and generic procedures in the literature on extraction from 
biological matrices, it had to be determined through the process of 
validation whether the method was fit for its intended use. 
Stock solutions, each at a concentration of 1 mg/mr, were used for the 
preparation of the working solutions. A mixture of these calibration 











standards and diluting to 6 m! with methanol. An internal standard, 
prazepam, was added to each mixture to give a fixed concentration of 
20 !-Ig/m!. Dilutions were made from this mixture to obtain 
concentrations, for each drug, of 40 !-Ig/m!, 35 !-Ig/m!, 30 !-Ig/m!, 25 
!-I9/m!, 20 !-Ig/m!, 15 !-Ig/m!, 10 !-Ig/m!, 5 !-Ig/m! and 3 !-Ig/m! respectively. 
A calibration curve was established for each drug. The internal 
standard, prazepam, was added to all the samples and standards in 
order to compensate for variations such as injection volume and 
detector performance during the analysis. The concentration of each 
analyte, calculated using the internal standard, is given by the formula: 
C unknown = A ISTDI X A unknown 
A ISTD2 A known 
where Cunknown is the concentration of the analyte, 
A1STD1 is the peak area of the internal standard in the standard, 
A1sTD2 is the peak area of the internal standard in the sample, 
Aunknown is the area of the sample peak, and 
Aknown is the area of the standard peak. 
5.2 SPECIFICITY 
Specificity is the ability of a method to differentiate and measure the 
analyte accurately in the presence of interfering components in the 
matrix. The specificity was investigated by analysing blank urine 
samples obtained from four sources as well as two urine samples to 
which internal standard had been added. Specificity is established by 
ensuring that the sample matrix is free from interfering peaks and that 
the signal produced is due to the analyte only and not a chemically or 
physically similar or any other compound. No peaks that interfere with 
any of the compounds of interest were observed in the chromatograms 













Accuracy expresses the closeness of agreement between the value 
that is accepted as a conventional true value, or an accepted reference 
value, and the value found [55]. In this study, the accuracy was 
investigated by analysing three separate urine aliquots that had been 
spiked at the three concentration levels of 50 %, 100 % and 150 % of 
the target concentration of 20 I-Ig/mt (that is, 10 I-Ig/mt, 20 I-Ig/mt and 30 
I-Ig/mt respectively) in triplicate. The accuracy of the method was 
determined by calculating the percentage recovery of the spiked 
analyte based on the value of the certified reference material. It is 
given by the formula: 
(c -c ) 
Recovery = s u x 100 
ca 
where 
Cs is the measured analyte concentration in the spiked sample, 
Cu is the measured analyte concentration in the unspiked sample, and 
Ca is the calculated analyte concentration in the spiked sample. 
The accuracy of the analytical procedure was measured by calculating 
the average percentage recoveries, with three analyses by GC-MS 
SIM, and the relative standard deviation (RSD) in each case. RSD is 
calculated as follows: 
s 
RSD = =xl00, 
x 
where s is the standard deviation, with s = -I-I (Xi _ ~)2 , 
n -1 i=l 
- - 1 n 
x is the average of the observed values, with x = - I Xi , 
n i=l 











Xi are the observed values. 
The results are given in Table 5.1. 
Table 5.1 Average percentage recovery and relative 
standard deviation (RSD; n = 3) for the seven drugs spiked 











at 10 IJg/mt at 20 IJg/mt at 30 IJg/mt 
cocaine 98.5 5.4 98.9 12.2 101.5 
imipramine 94.3 14.0 106.7 6.1 96.5 
lorazepam 20.9 13.8 15.3 10.9 13.7 
methamphetamine 100.2 4.6 104.0 1.3 101.9 
oxazepam 48.4 9.7 42.4 10.5 56.9 
phenobarbital 67.6 7.3 63.0 10.4 65.8 
secobarbital 54.2 8.8 57.3 8.8 50.6 
The recoveries obtained for this procedure range from 13.7 % for 
lorazepam to 106.7 % for imipramine. The results obtained for 
cocaine, imipramine and methamphetamine compared well with the 
certified values of these analytes. Lower recoveries were, however, 
obtained for the other analytes extracted, with lorazepam yielding the 
lowest recovery. This indicated that the procedure was not optimal for 
the effective extraction of lorazepam, oxazepam, phenobarbital or 
secobarbital, or, by implication, of benzodiazepines or barbiturates in 
general. Variable analytical recoveries of benzodiazepines are often 
attributed to their limited solubility in water, and methods involving 
chemical derivatization to improve their detection have been reported 
[21]. It is also possible that the wash solvent, hexane, used during the 
extraction process, removed some of the hydrophobically bound 
compounds. While hexane is very effective in removing traces of water 
prior to analyte elution, it is also one of the least polar solvents and 




















recoveries for the barbiturates were, on average, acceptable and could 
possibly be improved by increasing the sample volume or decreasing 
the amount of phosphate buffer added. The RSDs were, in general, 
fairly consistent at the three concentration levels, with 
methamphetamine having the lowest RSD of all the compounds 
extracted. 
Compared to the results obtained during the method development 
stage (Chapter 4), which was performed using the same extraction 
column but without an internal standard, similarly lower recoveries 
were observed for lorazepam, oxazepam, phenobarbital and 
secobarbital, but with higher RSD values. At a spiked concentration of 
20 ~g/mi, the average percentage recoveries, for three extractions, of . 
lorazepam, oxazepam, phenobarbital and secobarbital were 30.5 %, 
29.2 %, 17.2 % and 47.3 % respectively, whereas during the method 
validation stage, for the same spiked concentration, the average 
percentage recoveries, for three extractions, were 15.3 %, 42.4 %, 63.0 
% and 57.3 % respectively. This shows the beneficial effect of the 
internal standard in producing more consistent results. 
5.4 PRECISION 
The precision of an analytical procedure is the closeness of agreement, 
or degree of scatter, among individual test results when the procedure 
is applied repeatedly to multiple samples under the same conditions. 
The two most common precision measures are repeatability and 
reproducibility. They represent the two extreme measures of precision 
that can be obtained. Repeatability, which is the smallest expected 
precision, indicates the variability to be expected when a method is 
performed in duplicate by a single analyst on one piece of equipment 
over a short period of time. For a sample that is to be analysed by 
several laboratories for comparative purposes, reproducibility, which is 
the largest type of precision usually found and which excludes variation 
with respect to time, is the preferred measure of precision. Precision 











variability between different analysts, over an extended period, within a 
single laboratory: this is called intermediate precision [55]. The 
precision data in this study covers repeatability and intermediate 
precision. Precision is expressed in terms of relative standard 
deviation [55, 56]. 
5.4.1 Repeatability 
Repeatability expresses the degree of scatter within a series of 
measurements obtained under the same operating conditions over a 
short period of time. This precision was determined by analysing, by 
means of GC-MS SIM, three separate urine aliquots that had been 
spiked and extracted at the three concentration levels in triplicate, and 
by repeating this process two days later. The repeatability was 
evaluated by calculating the relative standard deviations of the 
recoveries obtained for each compound at the three concentration 
levels on the different days. The results are given in Table 5.2. 
Table 5.2 Repeatability in terms of the RSD (n = 2) of the average 
percentage recoveries for the seven drugs spiked at three 
concentration levels and analysed on two different days 
average average average 
% recovery at RSD % recovery at RSD % recovery at 
compound 10 jJg/mt (%) 20 jJg/mt (%) 30 jJg/mt 
day 1 day 3 day 1 day 3 day 1 day 3 
cocaine 98.5 97.1 1.0 98.9 94.6 3.2 101.5 99.6 
imipramine 94.3 91.8 1.9 106.7 88.7 13.0 96.5 98.8 
lorazepam 20.9 19.7 4.2 15.3 14.7 2.8 12.7 13.4 
methamphetamine 100.2 99.2 0.7 104.0 107.5 2.3 101.9 105.7 
oxazepam 48.4 53.0 6.4 42.4 49.4 10.8 56.9 54.1 
phenobarbital 67.6 70.7 3.2 63.0 68.1 5.5 65.8 65.2 




















The average percentage recoveries obtained on day 1 and on day 3 
compare well with each other for all the compounds at all three 
concentration levels, and the relative standard deviations are all low. 
This indicates that no significant difference is expected between 
duplicate analyses when this method is used, thus meeting the criterion 
for good repeatability. The RSD values for imipramine, oxazepam, 
phenobarbital and secobarbital show more variation between the three 
concentration levels than do those for cocaine, lorazepam and 
methamphetamine. 
5.4.2 Intermediate precision 
Intermediate precision expresses the effect of variation within a 
laboratory such as different analysts over a period of time, or different 
instruments. Three separate urine aliquots were spiked and extracted 
at the three concentration levels in triplicate. Different instruments, 
GC-MS and GC-NPD, were used for the analysis in order to determine 
the intermediate preCision, which was evaluated by calculating the 
relative standard deviations of the recoveries obtained for each 











Table 5.3 Intermediate precision in terms of the RSO (n = 2) of the 
average percentage recoveries for the seven drugs spiked at three 
concentration levels and analysed on two different instruments; 
NO = not detected 
average average average 
% recovery at 
RSD 
% recovery at 
RSD 
% recovery at 
RSD 






GC- GC- GC- GC- GC- GC-
MS NPD MS NPD MS NPD 
cocaine 98.5 69.8 24.1 98.9 90.8 5.8 101.5 84.0 13.2 
imipramine 94.3 92.2 1.6 106.7 104.7 1.3 96.5 104.0 5.3 
lorazepam 20.9 31.4 28.4 15.3 NO - 12.7 56.0 89.1 
methamphetamine 100.2 66.7 28.4 104.0 118.0 8.9 101.9 111.0 6.0 
oxazepam 48.4 21.4 54.7 42.4 NO - 56.9 43.0 19.7 
phenobarbital 67.6 4.0 125.6 63.0 NO - 65.8 NO 
secobarbital 54.2 21.0 62.4 57.3 NO - 50.6 NO 
Even though all the fractions, both basic and acidic, were injected on 
the GC-NPD, not all the compounds were detected by the nitrogen-
phosphorus detector [54]. The GC-NPD response was erratic 
throughout the experiment, as the bead voltage to the detector was 
fluctuating and at times it was zero. As a result, oxazepam, 
phenobarbital and secobarbital at 20 ~g/mt, and phenobarbital and 
secobarbital at 30 ~g/mt, were not detected by GC-NPD. Even though 
it could not be shown conclusively what the effect of variation between 
the two instruments was, the results obtained for cocaine at 20 ~g/mt, 
for imipramine at all three concentration levels and for 
methamphetamine at 20 ~g/mt and 30 ~g/mt, indicated that the 
variation between the two instruments was minimal. 
5.5 Linearity of method 
The linearity of an analytical procedure (also referred to as range, 













obtain tests results that are directly proportional to the concentration (or 
amount) of compound in the sample. For a quantitative method it is 
necessary to establish the range of compound concentration over 
which the method may be applied. The upper and lower end of the 
working linear range should also include the target concentration, 
which in this study was 20 j..Ig/mt Within the working linear range, the 
signal response will have a linear (first order) or higher order 
(quadratic, logarithmic or point-to-point fit) relationship with the 
compound concentration. For a linear (first order) relationship, 
calculations based on a linear least squares regression provide useful 
information on the goodness of fit or correlation coefficient, but this 
calculation does not determine the linearity of the method. Linearity is . 
determined by the analysis of the regression residuals, which are the 
differences between the predicted and the actual values as functions of 
the known concentrations. For a method to be linear, the residuals, 
when plotted, should fall randomly on either side of the zero line over 
the linear range. If the plot of residu ls shows a systematic, rather 
than random, pattern about the zero line, then the working range is not 
considered linear [57]. The standard error of the estimate for 
regression measures the amount of variability in the points around the 
regression line. It is the standard deviation of the data points as they 
are distributed around the regression line. The calculation involves first 
finding the sum of the squares of the errors (SSE) and then using that 
value to find the standard error (SE). The standard error of estimate 
for regression is calculated as follows: 
ss = ss _ (ss xy y 
E Y SS 
x 
and SE = ~ 
-V~ 
where 
SS is the sum of the squares of the errors, 
E 
SS y is the sum of the squares of the dependent variable, 











SSXY is the sum of the squares of the cross-product, 
SE is the standard error of the estimate for regression, 
n is the number of samples [57]. 
The linearity of method was determined by preparing spiked samples 
at seven concentrations with equal intervals over the range 3 IJg/mt to 
30 IJg/mt Each sample was injected five times. Linearity was 
investigated by the calculation of the regression statistics and by 
calculating and plotting the residuals. The sum of the squares of 
regression statistics, and the calculation of these statistics for cocaine 
as an example, are given in Tables 5.4 and 5.5. The plot of the 
regression residuals over the linear range for cocaine is given in Figure· 
5.1. 
Table 5.4 Sum of squares of regression statistics (slope, 
intercept and coefficient of determination) as well as residual 
regression analysis (linearity of method and linearity range) 
coefficient of method 
slope intercept line equation: linearity compound determination linear? 
(m) (b) (~) y=mx+c range (YIN) 
cocaine 0.29 -0.23 1.00 Y = 0.29x - 0.23 Y 0- 30 ppm 
imipramine 0.19 0.62 0.97 y=0.19+0.62 Y 0- 30 ppm 
lorazepam 0.03 -0.30 0.75 y = 0.03x - 0.30 N 10 - 30 ppm 
methamphetamine 0.28 1.14 1.00 y = 0.28x + 1.41 Y 0- 30 ppm 
oxazepam 0.03 -0.11 0.79 y = 0.02x - 0.11 N 0- 30 ppm 
phenobarbital 0.03 0.16 0.96 y = 0.03x + 0.16 Y 0- 30 ppm 


















Table 5.5 Calculation of sum of squares for regression 
statistics fOf cocaine 
Sum of squares for regre ssion stat istics 
• , .' ., i 3 .00 o "C 9 ,00 2.49 0 69 
500 0.96 25.00 ' ''' 0"' '000 m 100 00 2730 74 5 
15 00 4.43 225.00 ",HC 1962 
'" 00 
5 98 400 00 11 8 60 35 -r6 
25 00 69'J 625.00 174 75 
'" 00 30 00 8,75 800 00 262.50 76.56 
10800 W e< 228400 657 88 18987 
1846957 Formula: 
617 7143 y"mx+c 





Figure 5.1 Plot of regression residuals of cocaine over the 
linear range 
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The coefficient of determination was calculated to be 1.00 for cocaine 
and methamphetamine. indicating excellent linearity. When 
considering the plot of the regreSSion residuals, imipramine, 











range, with the data points for these compounds falling randomly on 
either side of the zero line, even though their coefficients of 
determination range from 0.95 to 0.97. Lorazepam and oxazepam, 
however, demonstrate a slightly more systematic plot of regression 
residuals, with their coefficients of determination being 0.75 and 0.79 
respectively, which indicates a non-linear response. 
5.6 LIMIT OF DETECTION (LOD) 
The LOD, expressed as the concentration CL or the quantity qL" is 
derived from the smallest measure, XL, that can be detected with 
reasonable certainty for a given analytical procedure. The value of XL . 
is given by the equation: 
where Xbl is the mean of the blank measurements, Sbl is the standard 
deviation of the blank measurements, and k is a numerical factor 
chosen according to the confidence level desired [55]. 
When measurements are made at low concentration levels, for 
example in trace analysis, it is necessary to know what the lowest 
concentration of the compound is that can be confidently detected by 
the method. Several proposed approaches exist in the literature for the 
determination of LOD. In the "blank + 3s" approach, blank matrix 
samples are measured and the standard deviation, s, determined. The 
LOD is expressed as the analyte concentration corresponding to (a) 
the mean sample blank value + 3s or (b) 0 + 3s. This approach is, 
however, useful only when the sample blank gives a non-zero standard 
deviation. Furthermore, both the mean and the standard deviation of 
the sample blank are likely to be dependent on the matrix of the 
sample blank. The LOD will therefore be matrix dependent. A slightly 
more exact approach is to measure blank samples that have been 
spiked with the analyte( s) of interest at the lowest acceptable 











values is calculated, and the LOD is expressed as the analyte 
concentration corresponding to the sample blank value + 4.658, which 
derives from hypothesis testing [55-57]. 
Another approach is to determine the concentration below which 
specificity becomes unreliable [55]. The results may vary if the 
experiment is repeated at a different time with different reagents or 
spiking materials. Sample blanks are spiked with the compound at 
decreasing concentration levels and then measured. A response curve 
of results versus concentration is used to determine, by inspection, the 
concentration at which the test becomes unreliable. In this study, the 
LOD was determined in this way by injecting extracts of spiked 
samples, three times, at decreasing concentration levels. It was 
possible to differentiate the concentration of 2.5 IJg/mt from 
background levels for all the drugs, except oxazepam and lorazepam, 
for which the threshold concentrations were 5 IJg/mt and 10 IJg/mt 
respectively. 
5.7 LIMIT OF QUANTIFICATION (LOQ) 
The LOa of an analytical procedure is the lowest amount of compound 
in a sample that can be quantitatively determined with suitable 
accuracy and precision. It is a parameter of quantitative assays for low 
levels of compounds in sample matrices and is used particularly for the 
determination of impurities and/or degradation products. The ability to 
quantify is generally expressed in terms of the signal of analyte (true) 
value that will produce estimates having a specified relative standard 
deviation (RSD), commonly 10 %. 
Thus: 
La = ka Oa 
where La is the LOa, Oa is the standard deviation at that point, and ka 
is the multiplier whose reciprocal equals the selected quantifying RSD. 











This value can also be determined experimentally by injecting 
standards of decreasing concentration and establishing the lowest 
concentration at which each drug can be measured. This approach 
was used in the present study and it showed that 3 IJg/m! is the lowest 
concentration at which all the drugs can be measured with acceptable 
accuracy and precision, except oxazepam and lorazepam, which 
required concentrations of 5 IJg/m! and 10 IJg/m! respectively. 
5.8 CONCLUSIONS 
The SPE method is capable of selectively extracting cocaine, 
imipramine, lorazepam, methamphetamine, oxazepam, phenobarbital. 
and secobarbital from a urine matrix, without extracting co-eluting 
substances. The matrix of the test material covered by this validation 
was only urine. The concentration range covered by the validation was 
2.5 IJg/m! to 30 IJg/m! for the spiked compounds. Good resolution was 
obtained for all the compounds, including the internal standard. 
In the accuracy studies, good recoveries were obtained for cocaine, 
imipramine and methamphetamine, with their average recoveries being 
99.6 %, 99.2 % and 102.0 % respectively. The precision studies 
indicated good repeatability for these drugs. The test for intermediate 
precision was not conclusive for all the drugs spiked, because of the 
poor performance of the GC-NPD instrument. Nevertheless, the RSD 
for cocaine at 20 IJg/m! was 5.8 %; for imipramine at the three 
concentration levels, the RSDs were 1.6 %, 1.3 % and 5.3 % 
respectively; and for methamphetamine at 20 IJg/m! and 30 IJg/m!, the 
RSDs were 8.9 % and 6.0 % respectively. These values indicate that 
there was minimal variation between the two instruments for these 
compounds. 
The linearity studies gave excellent correlation for cocaine and 
methamphetamine, with both having a coefficient of determination of 











0.97. The regression residuals indicated linearity, with an equal 
distribution about the zero line for all three compounds within a range 
of 3 IJg/mt to 30 IJg/mt For the determination of LOD, it was found that 
the threshold concentration at which the test became unreliable for 
these three drugs was 2.5 IJg/mt The LOa formed part of the linearity 
of method determination, as it was determined individually by both 
these studies that the lowest analyte concentration that can be 
determined with an acceptable level of uncertainty is 3 IJg/mt For 
these three drugs, the SPE method has been successfully validated for 
linearity of method over the range 3 IJg/mt to 30 IJg/mt as well as for 
LOD and LOa. 
The accuracy studies for oxazepam, phenobarbital and secobarbital 
gave average recoveries of 49.2 %, 65.5 % and 54.0 % respectively. 
These lower recoveries could possibly be improved by applying more 
sample to the column than was used in this experiment. Another 
option is to change the wash solvent from hexane, which has a high 
relative eluting strength for non-polar compounds, to a more polar 
solvent like methanol. The precision studies showed repeatability for 
these drugs at an average RSD of 6.9 % for oxazepam, 5.9 % for 
phenobarbital and 9.7 % for secobarbital. Good linearity was obtained 
for phenobarbital and secobarbital with coefficients of determination of 
0.96 and 0.95 respectively, and with their regression residuals 
distributed equally about the zero line within a linear range of 3 IJg/mt 
to 30 IJg/mt For oxazepam, however, this could not be achieved: the 
coefficient of determination was only 0.79 and the regression residual 
showed a systematic trend rather that random distribution about the 
zero line. For the determination of LOD, it was found that the threshold 
concentration at which the test became unreliable was 2.5 IJg/mt for 
these three drugs. The LOa of phenobarbital and secobarbital was 
found to be 3.0 IJg/mt, while that of oxazepam was 5.0 IJg/mt 
The accuracy studies for lorazepam showed an average recovery of 











repeatability test gave consistent results, with RSDs for the three 
concentration levels of 4.2 %, 2.8 % and 3.8 % respectively. The test 
for linearity of method produced a coefficient of determination of only 
0.75 for this compound, for which the linear range was 10 !-Ig/m! to 30 
!-Ig/mt The LOD and LOa were determined to be 5 !-Ig/m! and 10 
!-Ig/m! respectively. The lack of linearity and the low coefficient of 
determination for lorazepam can be attributed to the degradation of this 
compound in the stock solution. This was investigated by reanalysing, 
over a period of three days, the stock solution from which the dilutions 
had been made, and it was confirmed that the lorazepam was 
decreasing in intensity and was then absent. Also, better linearity and 
correlation might have been obtained if the standards had been 
prepared individually and not by serial dilution, or if the standards had 
been checked against an independently prepared control standard 
from a different batch of material in order to rule out error as a result of 
the standard material and preparation. 
This method was developed using mainly GC-NPD as an instrument 
for detection and quantification of the investigated compounds, but, 
because of the inconsistency of the results obtained from this 
instrument, GC-MS with single-ion monitoring was used for the 
validation procedure. It was able to detect and quantify all the spiked 
compounds with good accuracy and resolution and with very little 












CONCLUSIONS AND FUTURE WORK 
6.1 CONCLUSIONS 
Liquid-liquid extraction procedures are still used for the systematic 
toxicological analysis of biological samples. SPE, however, allows the 
analyst to use smaller sample and solvent volumes; furthermore, it 
gives clean extracts, is capable of extracting a wide range of drugs, 
and lends itself to automation. The proposed solid-phase extraction . 
procedure using a copolymeric column and followed by GC-MS and 
GC-NPD analysis, provides an accurate determination of acidic, neutral 
and basic drugs in urine. For a general scr ening procedure, suitable 
conditions must exist for all the drugs being extracted, but extraction 
optimization for certain drugs only would negatively affect the recovery 
of others. 
The results of this study indicate that the developed methodology can 
be used for the isolation of various drug types from urine. By using a 
single, copolymeric CLEAN SCREEN® DAU COLUMN (200 mg, 3 mt 
capacity) during the method developments stage, drugs present in the 
pre-treated sample were effectively extracted and separated into two 
groups. The results obtained indicate that, in the screening of an 
unknown sample, the drug present in the first fraction should be acidic 
or neutral, and in the second fraction, the drug should be a basic one. 
When a drug is found in both fractions, this substance is likely to be a 
drug whose pKa is close to the pH of the extraction system. The 
advantage of the two separate fractions is that two drugs that have 
similar retention times, but different physical properties, can be 
separated into two fractions. The method was further tested by using 











to facilitate a better sample flow through the column, and with a view to 
potentially performing extractions from viscous matrices such as whole 
blood or tissue. Again, all the drugs were extracted from urine into two 
fractions. Better recoveries were obtained for the basic components 
with this column. The addition of DMF resulted in increased peak 
heights for cocaine, imipramine and methamphetamine with the use of 
the Xtrackr® column. The validation process was based on the 
proposed SPE procedure using the Xtrackr® column, with addition of 
the internal standard (prazepam) to the already extracted fractions prior 
to analysis. The ratios of the peak areas of the respective compounds 
and the peak area of prazepam were used for the recovery 
calculations. 
The RSD for repeatability precision was less than 13 % for all the 
compounds; the recovery for the basic drugs was between 94.3 % and 
106.7 %, and for the acidic drugs it was between 13.7 % and 67.6 %. 
This SPE method was fully validated for cocaine, imipramine and 
methamphetamine in terms of specificity, accuracy, repeatability 
precision, linearity of method, LOD and LOa. The recoveries for 
oxazepam, phenobarbital and secobarbital ranged between 42.4 % 
and 67.6 %. The SPE method in this study can be used as a general 
screening procedure for drugs and, if positive for benzodiazepines or 
barbiturates, then more specific extraction procedures can be 
performed for quantification. For example, the amount of water added 
in the sample preparation step can be reduced to increase the amount 
of compound present, or the sample volume can be increased. 
Specifically for the benzodiazepines, glucuronide formation is a major 
metabolic route and therefore hydrolization or deconjugation can be 
performed before analysis. The poor results for lorazepam were 












Although some drugs were not optimally extracted, the procedure used 
in this study showed potential as an effective means of doing 
systematic analysis of biological samples in a forensic laboratory. 
6.2 FUTURE WORK 
The success of the Xtrack"fID column in achieving clean extracts as well 
as acceptable recoveries for a wide range of drugs, could be extended 
to the extraction of post-mortem blood, serum, stomach contents, eye 
fluid and cerebrospinal fluid. These samples are considered to be 
more "difficult", as they are more viscous than urine and tend to form 
blockages in SPE columns, which would be obviated by the use of the 
Xtrack"fID column. The larger particle size of this column allows viscous 
samples to pass through the SPE cartridge evenly and uniformly 
without a significant amount of sample pre-treatment [54]. Because of 
the ability of the Xtrack"fID column to facilitate a uniform flow of more 
viscous samples, the FCL CTN is considering using these columns for 
the extraction of toxins from stomach and contents, liver and kidney 
samples. A few published applications that use this column for organ 
extraction, look promising [35], [53]. 
The method using the Xtrack"fID column could be adapted for use on an 
automated extraction system, which would improve productivity as user 
intervention during the extraction process would be minimized. The 
present study showed the limitations of performing analysis using GC-
NPD, but these were addressed by using GC-MS with SIM. Although 
sample decomposition at high temperature was reduced by the 
addition of DMF, this would not be required if the analysis was 
performed using LC-MS. A further improvement on this process would 
be the use of on-line SPE coupled with LC-MS/MS [58, 59]. Integration 
of sample extraction and LC into a single system permits direct 
injection of the sample. Instead of removing the eluted fractions to be 
dried and then reconstituted, the fractions are directly and 











volatile components in the sample caused by evaporation and also 
reduces user intervention even further. The combination of online SPE 
with MS/MS would allow the development of a high-throughput method, 
resulting in higher and more reproducible recoveries of a more diverse 
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ZYMARK RapidTrace Procedure 
step source destination mt mt/min 
liquid 
check 
1 Condition MeOH Aq. 3 12 No 
2 Condition H2O Aq. 3 12 No 
3 Condition pH 6.0 Aq. 1 12 No 
4 Load Sample Bio. 5 1 No 
5 Load Sample Bio. 2.2 1 No 
6 Purge-Cannula H2O Cannula 6 12 No 
7 Purge-Cannula MeOH Cannula 6 12 No 
8 Rinse H2O Aq. 3 12 No 
9 Rinse HAc Aq. 1 12 No 
10 Dry Time = 5 min No 
11 Rinse Hexane OrgSol 2 12 No 
12 Collect Hexane/Et Acetate (50:50) Fract1 6 2 No 
13 Rinse MeOH Org 3 12 No 
14 Dry Time = 5 min No 
15 Collect CH2CL2/1PAlNH40H (78/20/2) Fract2 3 2 No 
16 Rinse H2O Aq. 6 12 No 
17 Rinse MEOH Aq. 6 12 No 
18 Purge-Cannula H2O Cannula 6 30 No 
19 Purge-Cannula MEOH Cannula 6 30 No 
Load Cannula Depth 0 Mix Volume .5 
Mix Cannula Depth 0 Mix Speed 30 
Mix Cycles 2 Reagent Mix Cycles 2 
Reagent Setup 
No. Reagent Name Abbreviation Sie Seeed 
1. Water H2O 30 
2. Methanol MEOH 30 
3. Hexane Hexane 30 
4. Acetic Acid 0.1 M HAc 30 
5. CH2CL2/1PAlNH40H (78/20/2) Elute 2 15 
6. Methylene Chloride MeCI 30 











8. Hexane/ Et Acetate (50:50) 
9. Mixing Vessel 
10. Sample 
Column air push volume 2 
Column air push volume speed multiplier 2 
No. Waste Name Abbreviation 
1. Aqueous Aq. 
2. Organic Solvent Org. 







Settings for RapidTrace analysis of acidic, basic and neutral 
drugs in urine and whole blood: automated method for GC or Ge-
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Measured responses and calculation of the sum of squares for 
regression statistics for cocaine 
